10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2016
OR
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from          to

Commission File No.  001-31332

LIQUIDMETAL TECHNOLOGIES, INC.

 (Exact name of Registrant as specified in its charter)

Delaware	33-0264467
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

30452 Esperanza

Rancho Santa Margarita, CA 92688

(Address of principal executive offices, zip code)

Registrant’s telephone number, including area code: (949) 635-2100

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.         

Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). 

Yes   ☒   No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☒ Non-accelerated filer ☐ Smaller reporting company ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes   ☐    No  ☒

The number of common shares outstanding as of November 11, 2016 was 882,481,151.

LIQUIDMETAL TECHNOLOGIES, INC.
FORM 10-Q
FOR THE QUARTER ENDED september 30, 2016

FORWARD-LOOKING INFORMATION

This Quarterly Report on Form 10-Q of Liquidmetal Technologies, Inc. contains “forward-looking statements” that may state our management’s plans, future events, objectives, current expectations, estimates, forecasts, assumptions or projections about the company and its business. Any statement in this report that is not a statement of historical fact is a forward-looking statement, and in some cases, words such as “believes,” “estimates,” “projects,” “expects,” “intends,” “may,” “anticipates,” “plans,” “seeks,” and similar words or expressions identify forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the anticipated outcomes or results. These statements are not guarantees of future performance, and undue reliance should not be placed on these statements. It is important to note that our actual results could differ materially from what is expressed in our forward-looking statements due to the risk factors described in the section of our Annual Report on Form 10-K for the year ended December 31, 2015 entitled “Risk Factors,” as well as the following risks and uncertainties:

● Our ability to fund our operations in the long-term through financing transactions on terms acceptable to us, or at all;

● Our history of operating losses and the uncertainty surrounding our ability to achieve or sustain profitability;

● Our limited history of developing and selling products made from our bulk amorphous alloys;

● Our limited history of licensing our technology to third parties;

● Lengthy customer adoption cycles and unpredictable customer adoption practices;

● Our ability to identify, develop, and commercialize new product applications for our technology;

● Competition from current suppliers of incumbent materials or producers of competing products;

● Our ability to identify, consummate, and/or integrate strategic partnerships;

● The potential for manufacturing problems or delays; and

● Potential difficulties associated with protecting or expanding our intellectual property position.

We undertake no obligation, other than as required by applicable law, to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

2

TABLE OF CONTENTS
PART I - Financial Information
	Item 1 – Financial Statements		4
		Consolidated Balance Sheets
		Consolidated Statements of Operations and Comprehensive Loss
		Consolidated Statement of Shareholders’ Equity
		Consolidated Statements of Cash Flows
		Notes to Consolidated Financial Statements
	Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations		19
	Item 3 – Quantitative and Qualitative Disclosures about Market Risk		24
	Item 4 – Controls and Procedures		24
PART II – Other Information
	Item 1 – Legal Proceedings		26
	Item 1A – Risk Factors		26
	Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds		26
	Item 3 – Defaults Upon Senior Securities		26
	Item 4 – Mine Safety Disclosures		26
	Item 5 – Other Information		26
	Item 6 – Exhibits		27
Signatures			28

3

PART I

FINANCIAL INFORMATION

Item 1 – Financial Statements

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

($ in thousands, except par value and share data)

	September 30, 2016			December 31, 2015
	(Unaudited)			(Audited)
ASSETS
Current assets:
Cash	$	6,402		$	2,773
Restricted cash		5			2,008
Trade accounts receivable, net of allowance for doubtful accounts		17			30
Inventory		227			83
Prepaid expenses and other current assets		452			408
Total current assets	$	7,103		$	5,302
Property and equipment, net		1,134			1,370
Patents and trademarks, net		518			570
Other assets		36			31
Total assets	$	8,791		$	7,273
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Short-term debt		-			700
Accounts payable		216			250
Accrued liabilities		1,695			947
Deferred revenue		13			77
Warrant liabilities, current		1,255			-
Option liabilities		-			-
Total current liabilities	$	3,179		$	1,974
Long-term liabilities:
Warrant liabilities, long-term		1,449			59
Other long-term liabilities		856			856
Total liabilities	$	5,484		$	2,889
Shareholders' equity:
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively		-			-
Common stock, $0.001 par value; 1,100,000,000 shares authorized; 582,332,818 and 477,149,485 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively.		582			477
Warrants		18,179			18,179
Additional paid-in capital		216,357			203,735
Accumulated deficit		(231,743	)		(217,945	)
Non-controlling interest in subsidiary		(68	)		(62	)
Total shareholders' equity		3,307			4,384
Total liabilities and shareholders' equity	$	8,791		$	7,273

The accompanying notes are an integral part of the consolidated financial statements.

4

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS and COMPREHENSIVE LOSS

($ in thousands, except share and per share data)

(unaudited)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2016			2015			2016			2015
Revenue
Products	$	154		$	42		$	329		$	80
Licensing and royalties		-			-			27			27
Total revenue		154			42			356			107
Cost of sales		165			160			336			312
Gross profit (loss)		(11	)		(118	)		20			(205	)
Operating expenses
Selling, marketing, general and administrative		1,679			1,763			5,461			5,506
Research and development		548			491			1,730			1,428
Total operating expenses		2,227			2,254			7,191			6,934
Operating loss		(2,238	)		(2,372	)		(7,171	)		(7,139	)
Change in value of warrant liabilities, gain (loss)		563			1,138			(1,885	)		1,326
Change in value of option liabilities, loss		-			-			(2,613	)		-
Loss on contract modification		(2,126	)		-			(2,126	)		-
Interest expense		(1	)		(1	)		(9	)		(1	)
Interest income		-			5			-			19
Net loss and comprehensive loss		(3,802	)		(1,230	)		(13,804	)		(5,795	)
Net loss attributable to non-controlling interest		2			2			6			6
Net loss and comprehensive loss attributable to Liquidmetal Technologies shareholders	$	(3,800	)	$	(1,228	)	$	(13,798	)	$	(5,789	)
Net loss per common share attributable to Liquidmetal Technologies shareholders, basic and diluted	$	(0.01	)	$	(0.00	)	$	(0.02	)	$	(0.01	)
Number of weighted average shares - basic and diluted		582,332,818			475,816,152			558,918,003			468,890,226

The accompanying notes are an integral part of the consolidated financial statements.

5

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY

For the Nine Months Ended September 30, 2016

($ in thousands, except share data)

(unaudited)

	Preferred Shares		Common Shares		Common Stock		Warrants part of Additional Paid-in Capital		Additional Paid-in Capital		Accumulated Deficit			Non- Controlling Interest			Total
Balance, December 31, 2015		-		477,149,485	$	477	$	18,179	$	203,735	$	(217,945	)	$	(62	)	$	4,384
Common stock issuance, net of issuance costs				105,000,000		105				6,274								6,379
Stock option exercises				183,333		-				15								15
Stock-based compensation										1,083								1,083
Written call options										3,124								3,124
Loss on contract modification										2,126								2,126
Net loss												(13,798	)		(6	)		(13,804	)
Balance, September 30, 2016		-		582,332,818	$	582	$	18,179	$	216,357	$	(231,743	)	$	(68	)	$	3,307

The accompanying notes are an integral part of the consolidated financial statements.

6

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

($ in thousands, except per share data)

(unaudited)

	Nine Months Ended September 30,
	2016			2015
Operating activities:
Net loss	$	(13,804	)	$	(5,795	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		415			374
Bad debt expense		-			19
Stock-based compensation		1,083			1,035
Loss on contract modification		2,126			-
Restricted stock compensation issued to officer		-			182
Loss (gain) from change in value of warrant liabilities		1,885			(1,326	)
Loss from change in value of option liabilities		2,613			-
Changes in operating assets and liabilities:
Trade accounts receivable		13			44
Inventory		(144	)		(111	)
Prepaid expenses and other current assets		(44	)		(17	)
Other assets		(5	)		-
Accounts payable and accrued liabilities		(36	)		323
Deferred revenue		(64	)		22
Net cash used in operating activities		(5,962	)		(5,250	)
Investing Activities:
Purchases of property and equipment		(105	)		(650	)
Decrease (increase) in restricted cash		2,003			(2,006	)
Investment in patents and trademarks		(22	)		-
Net cash provided by (used in) investing activities		1,876			(2,656	)
Financing Activities:
Proceeds from short-term debt		-			700
Repayment of short-term debt		(700	)		-
Proceeds from exercise of stock options		15			13
Proceeds from common stock issuance, net of issuance costs		8,400			1,568
Net cash provided by financing activities		7,715			2,281
Net increase (decrease) in cash		3,629			(5,625	)
Cash at beginning of period		2,773			10,009
Cash at end of period	$	6,402		$	4,384
Supplemental Schedule of Non-Cash Investing and Financing Activities:
Accrued stock issuance costs	$	(750	)		-

The accompanying notes are an integral part of the consolidated financial statements.

7

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

1. Description of Business

Liquidmetal Technologies, Inc. (the “Company”) is a materials technology and manufacturing company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilizes the advantages offered by amorphous alloys technology. The Company designs, develops, manufactures and sells custom products and components from bulk amorphous alloys to customers in a wide range of industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products.

Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. The Company’s alloys and the injection molding technology it employs result in components that exhibit: exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. Interestingly, all of these characteristics are achievable from the molding process, so design engineers do not have to select specific alloys to achieve one or more of the characteristics as is the case with crystalline materials. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.

The Company’s revenues are derived from i) selling bulk amorphous alloy custom products and components for applications which include, but are not limited to, non-consumer electronic devices, medical products, automotive components, and sports and leisure goods, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development, iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

2. Basis of Presentation and Recent Accounting Pronouncements

The accompanying unaudited interim consolidated financial statements as of and for the three and nine months ended September 30, 2016 and September 30, 2015 have been prepared in accordance with accounting principles generally accepted in the United States of America (“generally accepted accounting principles”) for interim financial information and in accordance with the instructions to Form 10-Q. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. All intercompany balances and transactions have been eliminated in consolidation. Operating results for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for any future periods or the year ending December 31, 2016. The accompanying unaudited consolidated financial statements should be read in conjunction with the Company's 2015 Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 7, 2016.

Revenue Recognition

The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of bulk amorphous alloy custom products and components, the tooling associated with production and prototyping projects, and licensing and royalty fees for the use of the Liquidmetal brand and certified Liquidmetal bulk amorphous alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.

License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.

Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

8

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

Fair Value Measurements

The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash, restricted cash, and short-term debt approximate their carrying value due to their short maturities.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

Level 1 — Quoted prices in active markets for identical assets or liabilities;

Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level 2 measurement inputs. These instruments are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing the accounting for certain financial instruments with characteristics of both liabilities and equity and derivative accounting. The fair value of such instruments is estimated using the Black-Scholes option pricing model. Due to the presence of certain anti-dilution and exercise price reset provisions, such instruments are required to be classified as liabilities (see Note 11).

As of September 30, 2016, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (current)		1,255		-		1,255		-
Warrant liabilities (long-term)		1,449		-		1,449		-

As of December 31, 2015, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (long-term)		59		-		59		-

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued an accounting standards update which modifies the accounting for leasing arrangements, particularly those arrangements classified as operating leases. This update will require entities to recognize the assets and liabilities arising from operating leases on the balance sheet. This guidance is effective for fiscal and interim periods beginning after December 15, 2018 and is required to be applied retrospectively to all leasing arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements.

Stock-Based Compensation

In March 2016, the FASB issued an accounting standards update which simplifies the accounting for share-based payment transactions, inclusive of income tax accounting and disclosure considerations. This guidance is effective for fiscal and interim periods beginning after December 15, 2016 and is required to be applied retrospectively to all impacted share-based payment arrangements. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

9

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

Revenue from Contracts with Customers

In May 2014, the FASB issued an accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective for fiscal and interim periods beginning after December 15, 2017 and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements.

Ability to Continue as a Going Concern

In August 2014, the FASB issued an accounting standards update which requires an assessment of an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently addressed by U.S. auditing standards. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Inventory

In July 2015, the FASB issued an accounting standards update which modifies the requirements for measuring the value of inventory on a periodic basis. The new requirement will be to measure inventory at the lower of cost or net realizable value. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

3. Significant Transactions

2016 Purchase Agreement

On March 10, 2016, the Company entered into a Securities Purchase Agreement (the “2016 Purchase Agreement”) with Liquidmetal Technology Limited, a Hong Kong company (the “Investor”), providing for the purchase by the Investor of up to 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400.

The 2016 Purchase Agreement provided that the Investor is obligated to purchase up to 405,000,000 shares of the Company’s common stock in multiple closings, with the Investor having purchased 105,000,000 shares at an aggregate purchase price of $8,400 (or $0.08 per share) at the initial closing on March 10, 2016. The 2016 Purchase Agreement provided that the Investor will purchase the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55,000 after the satisfaction of certain conditions, including Company shareholder approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation increasing the Company’s authorized number of shares of common stock from 700,000,000 to 1,100,000,000 (the “Charter Amendment”).

In addition to the shares issuable under the 2016 Purchase Agreement, the Company also issued to the Investor a warrant to acquire 10,066,809 shares of common stock of the Company at an exercise price of $0.07 per share. The warrant vests in increments on each closing date under the 2016 Purchase Agreement for a number of warrant shares that is proportionate to the amount of shares purchased under the 2016 Purchase Agreement on such closing date (with 2,609,913 warrant shares having initially vested on March 10, 2016 and the remaining 7,456,896 warrant shares vesting on October 26, 2016). The warrant will expire on the 10th anniversary of its issuance date.

The 2016 Purchase Agreement also provided that the Investor would have the right to designate one individual to serve on the Company’s Board of Directors. Once the Investor purchases the remaining 300,000,000 shares of common stock under the 2016 Purchase Agreement, the Investor would thereafter have the right to designate an additional two individuals to serve on the Company’s Board of Directors (such that the Investor would have designation rights with respect to three of the seven members of the Company’s Board of Directors, with one such member serving as Chairman). The 2016 Purchase Agreement also provided that, with certain limited exceptions, if the Company issues any shares of common stock at any time through the 5th anniversary of the Purchase Agreement, the Investor will have a preemptive right to subscribe for and to purchase at the same price per share (or at market price, in the case of issuance of shares pursuant to stock options) the number of shares necessary to maintain its ownership percentage of Company-issued shares of common stock.

On May 19, 2016, the Company’s shareholders approved the Charter Amendment, thereby obligating the Investor to purchase the remaining 300,000,000 shares of the Company’s common stock for the aggregate purchase price of $55,000. 

10

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

On October 26, 2016, the Company issued and sold to the Investor an aggregate of 300,000,000 shares of Company’s common stock for an aggregate purchase price of $55,000, comprised of 200,000,000 shares at a price of $0.15 per share and 100,000,000 shares at a price of $0.25 per share. As a result of this closing, the Investor has completed its entire investment in the Company contemplated by the 2016 Purchase Agreement.

Eontec License Agreement

In connection with the 2016 Purchase Agreement and also on March 10, 2016, the Company and DongGuan Eontec Co., Ltd., a Hong Kong corporation (“Eontec”), entered into a Parallel License Agreement (the “License Agreement”) pursuant to which the Company and Eontec entered into a cross-license of their respective technologies.

The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between the Company and Eontec. In particular, under the License Agreement, the Company granted to Eontec a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to the Company’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of North America and Europe, and Eontec granted to the Company a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of specified countries in Asia. The license granted by the Company to Eontec is exclusive (including to the exclusion to the Company) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, North Korea, Philippines, Singapore, South Korea, Thailand and Vietnam. The license granted by Eontec to the Company is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories.

2014 Purchase Agreement

On August 20, 2014, the Company entered into a common stock purchase agreement (“2014 Purchase Agreement”) with Aspire Capital Fund LLC (“Aspire Capital”), which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital would be committed to purchase up to an aggregate of $30,000 worth of the Company’s common stock, $0.001 par value, over the 36-month term of the 2014 Purchase Agreement.

On March 9, 2016, the Company terminated the 2014 Purchase Agreement. As of the date of termination, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share.

Line of Credit Facility

In February 2015, the Company entered into a $2,000 line of credit facility, with a fixed interest rate of 2.1%, which originally matured on February 13, 2016. The facility was extended through August 25, 2016, with reductions in available borrowings and associated collateral requirements to $1,000. On August 26, 2016, the Company fully repaid all outstanding principal and accrued interest balances due under the facility. As of such date, all collateral to the facility was released. Interest expense applicable to these borrowings was $1 and $9 for the three and nine months ended September 30, 2016, respectively, and $1 and $1 for the corresponding three and nine month periods ended September 30, 2015, respectively.

Apple License Transaction

On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Additionally, in connection with the license transaction, Apple required the Company to complete a statement of work related to the exchange of Liquidmetal intellectual property information. The Company recognized a portion of the one-time license fee upon receipt of the initial payment and completion of the foregoing requirements under the license transaction. The remaining portion of the one-time license fee was recognized at the completion of the required statement of work.

Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property that it developed through February 2012. Subsequently, this obligation was extended to apply to all intellectual property developed through February 2016. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.

11

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

Visser Precision Cast, LLC License Agreement

On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing. On May 20, 2014, the Company and Visser entered into a settlement agreement significantly amending the Visser MTA, whereby the Company granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014 (the “Effective Date”). Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date. The license to the Company’s intellectual property developed on or prior to the Effective Date does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement.

With the foregoing revised arrangements, the Company is no longer required to use Visser as its exclusive manufacturer and is free to license other manufacturers on a non-exclusive basis in any industry or geographic market as to which the Company has not previously granted an exclusive license to a third party. Additionally, the settlement amended and restated the two warrants the Company issued to Visser in June 2012 to purchase 15,000,000 shares of the Company’s common stock at an exercise price of $0.22 per share. The amended and restated warrant agreement includes the effect of anti-dilution adjustments and is exercisable for 18,611,079 shares of common stock (increased further to 21,126,522 shares under the anti-dilution provisions of the warrants, see Note 11) at an exercise price of $0.17 per share (further reduced to $0.16 per share under the anti-dilution provisions of the warrants, see Note 11).

Other License Transactions

On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel.  On December 6, 2013, the companies entered into an Exclusivity Agreement for a 10 year term whereby the Company agreed, with certain exceptions and limitations, that the Company and its licensees would purchase amorphous alloy injection molding machines exclusively from Engel, and this exclusivity right was granted in exchange for certain royalties to be paid by Engel to the Company based on a percentage of the net sales price of such injection molding machines.

The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. The Company owns 79% of the outstanding common stock of Liquidmetal Golf.

In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”).  Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets.  The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021.

In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches and all third parties (including the Company), but non-exclusive as to Apple, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

4. Liquidity and Capital Resources

For the nine months ended September 30, 2016, the Company’s cash used in operations was $5,962, cash flows from investing activities were $1,876, primarily due to reductions in restricted cash as a result of collateral requirement reductions, and cash provided by financing activities was $7,715 due to cash received from equity sales under the 2016 Purchase Agreement and the exercise of stock options. As of September 30, 2016, the Company’s cash and restricted cash balance was $6,407, which consisted of $6,402 of cash and $5 of short-term restricted cash.

On March 10, 2016, the Company entered into the 2016 Purchase Agreement providing for the purchase by the Investor of up to 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400.

The 2016 Purchase Agreement provides that the Investor is obligated to purchase up to 405,000,000 shares of the Company’s common stock in multiple closings, with the Investor having purchased 105,000,000 shares at an aggregate purchase price of $8,400 (or $0.08 per share) at the initial closing on March 10, 2016, with the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55,000 closing on October 26, 2016 (see Note 3).

The Company has a relatively limited history of producing bulk amorphous alloy products and components on a mass-production scale. Furthermore, the ability of future contract manufacturers to produce the Company’s products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of the Company’s control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. These factors have required that the Company engage in equity sales under various stock purchase agreements to support its operations and strategic initiatives. Uncertainty as to the outcome of these factors has previously raised substantial doubt about the Company’s ability to continue as a going concern. Following the closing of the remaining funding under the 2016 Purchase Agreement, the Company anticipates that its current capital resources, when considering expected losses from operations, will be sufficient to fund the Company’s operations for the foreseeable future.

12

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

5. Inventory

Inventory totaled $227 and $83 as of September 30, 2016 and December 31, 2015, respectively, and primarily consisted of raw alloy and finished goods inventory to satisfy future customer orders. Inventory is stated at the lower of weighted-average cost or market.

6. Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets totaled $452 and $408 as of September 30, 2016 and December 31, 2015, respectively, and primarily consisted of prepaid invoices and insurance premiums that will be recognized as expenses at a timing consistent with when the associated services are provided.

7. Patents and Trademarks, net

Net patents and trademarks totaled $518 and $570 as of September 30, 2016 and December 31, 2015, respectively, and primarily consisted of purchased patent rights and internally developed patents.

Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees or other amounts will be payable in the future under the license agreement.

In addition to the purchased and licensed patents, the Company has internally developed patents. Internally developed patents include legal and registration costs incurred to obtain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

The Company amortizes capitalized patents and trademarks over an average of 10 to 17 year periods. Amortization expense for patents and trademarks was $25 and $74 for the three and nine month periods ended September 30, 2016, respectively. This compares to $24 and $74 for the three and nine month periods ended September 30, 2015, respectively.

8. Other Assets

Other assets totaled $36 and $31 as of September 30, 2016 and December 31, 2015, respectively, and consisted of deposits under long-term lease agreements.

9. Accrued Liabilities

Accrued liabilities totaled $1,695 and $947 as of September 30, 2016 and December 31, 2015, respectively. Included within these totals are the following:

	September 30, 2016		December 31, 2015
Accrued payroll, vacation, and bonuses	$	783	$	766
Accrued stock issuance costs		750		-
Accrued audit fees		71		109
Straight-line rent accruals		91		72
Total		1,695		947

The Company entered into a non-exclusive investment banking engagement agreement with an investment banking firm during 2012 to provide support to the Company in the identification of potential investors for future strategic transactions or financing transactions. The services provided by the investment banking firm did not result in the identification of any practicable investment transactions and the agreement was considered effectively terminated by the Company during 2013, although no formal notice of termination was ever provided by either party. During the three-months ended September 30, 2016, the Company was contacted and advised by a representative of the investment banking firm that the firm did not consider the engagement agreement to be terminated and that amounts raised under the 2013, 2014, and 2016 Purchase Agreements may be subject to success fees stipulated under their investment banking agreement. The firm advised the Company that such success fees would, based on the language of the engagement agreement, be equal to the greater of (i) 5% of the total proceeds received as a result of equity transactions or (ii) $500. To date no formal claims have been filed against the Company. Subsequent to September 30, 2016, the Company reached a settlement with respect to any and all amounts allegedly due under the engagement agreement in the amount of $750. As a result of the settlement, the engagement agreement is deemed to be terminated in all respects as of the settlement date of November 8, 2016. Such amounts have been reflected as an accrued liability as of September 30, 2016 and reflected as stock issuance costs as a reduction to additional paid in capital. 

10. Short-Term Debt

Short-term debt totaled $0 and $700 as of September 30, 2016 and December 31, 2015, respectively, and consisted of borrowings under a line of credit facility, with a fixed interest rate of 2.1%. All borrowings were fully repaid upon maturity of the facility on August 26, 2016. Interest expense related to outstanding borrowings was $1 and $9 for the three and nine months ended September 30, 2016, respectively. This compares to $1 and $1 for the corresponding three and nine month periods ended September 30, 2015.

This credit facility required the Company to maintain collateral for the full amount of the facility. Following maturity of the facility all collateral requirements have been removed.

13

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

11. Warrant Liabilities

Pursuant to FASB ASC 815, the Company is required to report the value of certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its consolidated statement of operations and comprehensive loss due to the price-based anti-dilution rights of the warrants.

During June 2012, the Company issued warrants to purchase a total of 15,000,000 shares of common stock to Visser under the Visser MTA Agreement (see Note 3). These warrants had an original exercise price of $0.22 per share, expire on June 1, 2017 and were originally valued at $4,260. These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of subsequent issuances of the Company’s common stock, which resulted in anti-dilutive price resets, the exercise price of these warrants was reduced to $0.16 and $0.17 as of September 30, 2016 and December 31, 2015, respectively. In addition, the number of shares to be issued under the warrants as a result of the anti-dilution provision increased to 21,126,522 and 18,937,931 as of September 30, 2016 and December 31, 2015, respectively. As of September 30, 2016, these warrants were valued at $691 under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 0.67 years, (ii) volatility of 72%, (iii) risk-free interest rate of 0.6%, and (iv) dividend rate of 0. The change in fair value for these warrants was a (gain) loss of $(292) and $657 for the three and nine months ended September 30, 2016, respectively.

On July 2, 2012, the Company issued warrants to purchase a total of 18,750,000 shares of common stock in a private placement (the “July 2012 Private Placement”). These warrants have an exercise price of $0.384 per share, expire on July 2, 2017, and were originally valued at $5,053. These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of contractually defined price resets, and issuances under the 2014 and 2016 Purchase Agreements, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to $0.17 and $0.19 as of September 30, 2016 and December 31, 2015, respectively. As of September 30, 2016 there were warrants to purchase a total of 17,572,000 shares of common stock outstanding, which were valued at $564 under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 0.75 years, (ii) volatility of 76%, (iii) risk-free interest rate of 0.6%, and (iv) dividend rate of 0. The change in fair value for these warrants was a (gain) loss of $(172) and $539 for the three and nine months ended September 30, 2016, respectively.

On March 10, 2016, the Company issued warrants to purchase a total of 10,066,809 shares of common stock as part of the 2016 Purchase Agreement. These warrants have an exercise price of $0.07 per share, expire on March 10, 2026, and were originally valued at $760. These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As of September 30, 2016, these warrants were valued at $1,449 under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 9.44 years, (ii) volatility of 120%, (iii) risk-free interest rate of 1.60%, and (iv) dividend rate of 0. The change in fair value for these warrants was a (gain) loss of $(99) and $689 for the three and nine months ended September 30, 2016, respectively.

The following table summarizes the change in the Company’s warrant liabilities as of September 30, 2016:

	Visser MTA Agreement		July 2, 2012 Private Placement		2016 Purchase Agreement		Total
Beginning Balance - December 31, 2015	$	34	$	25	$	-		59
Original valuation- new issuances		-		-		760		760
Change in value of warrant liabilities, loss		657		539		689		1,885
Ending Balance - September 30, 2016	$	691	$	564	$	1,449	$	2,704
Included in current liabilities	$	691	$	564	$	-	$	1,255
Included in long-term liabilities	$	-	$	-	$	1,449	$	1,449

The Company had warrants to purchase 48,765,331 and 36,509,931 shares of common stock outstanding as of September 30, 2016 and December 31, 2015, respectively, which were valued and classified as liabilities under FASB ASC 815.

14

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

12. Option Liabilities

As part of the 2016 Purchase Agreement, executed on March 10, 2016, the Company granted the Investor the right to purchase shares of the Company’s common stock in the future at predetermined prices. These options allow the investor to purchase 200,000,000 shares of the Company’s common stock at a price of $0.15 per share and 100,000,000 shares of the Company’s common stock at a price of $0.25 per share. Given that the number of shares to be issued upon exercise of these options was in excess of the number of shares authorized for issuance, these options were originally required to be classified as liabilities under FASB ASC 815. The 200,000,000 share option and the 100,000,000 share option were initially valued at $489 and $22, respectively. Following the filing of the Charter Amendment, which allowed for adequate authorized shares, these options were revalued as of May 19, 2016 and reclassified to permanent shareholders’ equity. As of May 19, 2016, these written call options were valued at $2,931 and $193, respectively, under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 0.25 years, (ii) volatility of 85%, (iii) risk-free interest rate of 0.31%, and (iv) dividend rate of 0. The change in fair value for these options was a loss of $2,442 and $171, respectively, for the nine months ended September 30, 2016.

The following table summarizes the change in the Company’s option liabilities as of September 30, 2016:

	200M Share			100M Share
	Call Option			Call Option			Total
Beginning Balance - December 31, 2015	$	-		$	-			-
Original valuation		489			22			511
Change in value of option liabilities, loss		2,442			171			2,613
Reclassification to shareholders' equity		(2,931	)		(193	)		(3,124	)
Ending Balance - September 30, 2016		-			-			-

On August 11, 2016, the Company and the Investor entered into an amendment to the 2016 Purchase Agreement. Under the amendment, the Company agreed to extend the deadline for the Investor’s purchase of 300,000,000 additional shares of Company common stock under the 2016 Purchase Agreement from the original deadline of August 17, 2016 to a new deadline of December 31, 2016. Other than the extension of the deadline, the amendment does not materially modify the terms of the 2016 Purchase Agreement. As a result of this amendment the Company recorded an additional $2,126 of expense to additional paid in capital. Such amounts are reflected as a loss on contract modification within the consolidated statements of operations.

13. Other Long-Term Liabilities  

Other long-term liabilities were $856 as of September 30, 2016 and December 31, 2015, and consisted of long-term, aged payables to vendors, individuals, and other third parties that have been outstanding for more than 5 years. The Company is in the process of researching and resolving the balances for settlement and/or escheatment in accordance with applicable state law.

14. Stock Compensation Plans

Under the Company’s 2002 Equity Incentive Plan (the “2002 Plan”), which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries, the Company granted options to purchase the Company’s common stock.A total of 10,000,000 shares of the Company’s common stock were available for issuance under the 2002 Plan. The 2002 Plan expired by its terms in April 2012, but remains in effect only with respect to the equity awards that had been granted prior to its expiration. The Company had outstanding grants of options to purchase 507,500 and 822,000 shares of the Company’s common stock as of September 30, 2016 and December 31, 2015, respectively.

On June 28, 2012, the Company adopted its 2012 Equity Incentive Plan, with the approval of the Company’s shareholders, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. All options granted under this plan had exercise prices that were equal to the fair market value on the dates of grant. During the nine months ended September 30, 2016, the Company granted options to purchase 2,000,000 shares of common stock. Under this plan, the Company had outstanding grants of options to purchase 25,746,985 and 25,988,734 shares of the Company’s common stock as of September 30, 2016 and December 31, 2015, respectively.

On January 27, 2015, the Company adopted its 2015 Equity Incentive Plan, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of 40,000,000 shares of the Company’s common stock are authorized for issuance under this plan. All options granted under this plan had exercise prices that were equal to the fair market value on the dates of grant. During the nine months ended September 30, 2016, the Company granted options to purchase 14,400,000 shares of common stock. Under this plan, the Company had outstanding grants of options to purchase 27,500,000 and 15,100,000 shares of the Company’s common stock as of September 30, 2016 and December 31, 2015, respectively.

Stock based compensation expense attributable to these plans was $365 and $1,083 for the three and nine months ended September 30, 2016, respectively. This compares to $320 and $1,035 for the three and nine months ended September 30, 2015, respectively.

15

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

15. Shareholders’ Equity

Common Stock

In June 2012, the Company issued 30,000,000 shares of common stock to Visser in connection with the Visser MTA Agreement (see Note 3).

Pursuant to the terms of the Company’s Senior Convertible Notes due September 1, 2013, which were issued in the July 2012 Private Placement, the Company opted to pay the twelve monthly installment payments prior to the September 1, 2013 maturity date with shares of the Company’s common stock. Upon final settlement, the Company had issued 163,641,547 shares of common stock at a weighted average conversion price of $0.0774, for the twelve installment payments due under the notes, consisting of $12,000 of principal and $680 of interest.

During the year ended December 31, 2013, the holders of the Company’s Series A Preferred Stock converted all of the outstanding 506,936 shares of Series A Preferred Stock into 16,896,070 shares of the Company’s common stock. After giving effect to such conversion, the Company has no shares of preferred stock outstanding.

On February 28, 2013, the Company’s shareholders approved an amendment to the Certificate of Incorporation of the Company increasing the number of authorized shares of common stock from 400 million shares to 500 million shares.

On October 24, 2013, the Company’s shareholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 500 million shares to 700 million shares.

In connection with the execution of the 2013 Purchase Agreement, the Company issued to each of the 2013 Investors a pro rata portion of 2,666,667 shares of the Company’s common stock. As of December 31, 2014, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014.

On September 9, 2014, an initial registration statement covering 75,000,000 shares issued and issuable pursuant to the 2014 Purchase Agreement was declared effective by the SEC. As of September 30, 2015, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share. On March 8, 2016, the Company voluntarily terminated the 2014 Purchase Agreement, effective March 9, 2016 (see Note 3).

In connection with the execution of the 2016 Purchase Agreement, the Company issued 105,000,000 shares of the Company’s common stock, at a price of $0.08 per share, for gross proceeds of $8,400.

On May 19, 2016, the Company’s shareholders approved the Charter Amendment increasing the number of authorized shares of common stock from 700 million shares to 1,100 million shares.

Warrants

In connection with the Series A Preferred Stock issuances in 2009, warrants to purchase 29,779,557 shares of the Company’s common stock, valued at $18,179, were outstanding through July 15, 2015. Due to extension of the expiration date of these warrants during 2010, they no longer contained anti-dilution provisions and were reflected as equity as they did not meet the criteria under FASB ASC 815 for liability treatment. Such warrants had exercise prices ranging between $0.48 and $0.49 and expired on July 15, 2015.

Non-Controlling Interest

The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. The Company owns 79% of the outstanding common stock of Liquidmetal Golf. As of September 30, 2016, non-controlling interest was a deficit of $68. The December 31, 2015 non-controlling interest was a deficit of $62.

16. Loss Per Common Share

Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings.

Options to purchase 53,754,485 shares of common stock, at prices ranging from $0.07 to $0.77 per share, were outstanding at September 30, 2016, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 48,765,331 shares of common stock, with prices ranging from $0.07 to $0.17 per share, outstanding at September 30, 2016 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Written call options to purchase 300,000,000 shares of common stock, with prices ranging from $0.15 to $0.25 per share, outstanding at September 30, 2016 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

16

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

Options to purchase 42,558,733 shares of common stock, at prices ranging from $0.08 to $1.44 per share, were outstanding at September 30, 2015, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 36,509,931 shares of common stock, with prices ranging from $0.17 to $0.19 per share, outstanding at September 30, 2015 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss.

17. Commitments and Contingencies

Operating Lease Commitments

The Company leases its offices and warehouse facilities under various lease agreements, certain of which are subject to escalations based upon increases in specified operating expenses or increases in the Consumer Price Index. As of September 30, 2016 and December 31, 2015, the Company had recorded $91 and $72, respectively, of deferred rent expenses.

Rent expense was $56 and $169 for the three and nine months ended September 30, 2016, respectively. Rent expense was $56 and $169 for the three and nine months ended September 30, 2015, respectively.

18. Related Party Transactions

The Company entered into a license agreement (the “IMG License Agreement”) with Innovative Materials Group, LLC (“IMG”), a California limited liability company which is majority owned by Mr. Kang, a former Chief Executive Officer and former Chairman of the Company, to license certain patents and technical information for the limited purpose of manufacturing certain licensed products with the Company’s first generation die cast machines. The IMG License Agreement granted a non-exclusive license to certain product categories, as well as an exclusive license to specific types of consumer eyewear products and obligated IMG to pay the Company a running royalty based on its sales of licensed products through August 5, 2021. The Company recognized $0 in royalty revenues from IMG during the three and nine months ended September 30, 2016 and 2015. The IMG License Agreement was terminated on March 8, 2016.

In March 2016, the Company executed an Amended and Restated Employment Agreement with Mr. Steipp. The Restated Employment Agreement provides for an employment term from its effective date through August 3, 2017, after which the employment term is renewed annually for successive one year terms, unless terminated by the Company or Mr. Steipp. Under the Restated Employment Agreement, Mr. Steipp is entitled to certain benefits if his employment is terminated involuntarily. These benefits include payment of a lump sum amount equal to one year of his annual base salary, continued insurance benefits at the Company’s expense for one year and accelerated vesting of equity awards. If the Company undergoes a “change of control”, and Mr. Steipp (i) is subsequently terminated without “cause”, or (ii) the Company subsequently takes certain actions that constitute “good reason”, and thereafter Mr. Steipp resigns, he will be entitled to a payment equal to one year of base salary, plus continued insurance benefits for two years, plus acceleration of vesting on equity awards and an extended time during which to exercise any equity awards that are stock options.

In March 2016, the Company entered into amended Change of Control Agreements with certain of its executive officers. The Change of Control Agreements provide that if the executive officer’s employment with the Company is terminated without cause during the one-year period after a change of control of the Company, then the terminated officer will receive lump sum severance compensation in an amount equal to twelve months of his then-current base salary. Under the agreements, each of the executive officers will also be entitled to the above-described severance compensation in the event he terminates his own employment within one year after a change of control because of a salary decrease, assignment to a lower-level position, or a required move of more than twenty-five miles. In addition, upon termination, all unvested stock options related to these officers will automatically and immediately vest and shall thereafter be exercisable in accordance with the terms and provisions of the applicable award agreements.

On March 10, 2016, the Company entered into the 2016 Purchase Agreement with Liquidmetal Technology Limited, providing for the purchase of up to 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. Liquidmetal Technology Limited is a newly formed company owned by Professor Yeung Tak Lugee Li (“Professor Li”). In connection with the 2016 Purchase Agreement and also on March 10, 2016, the Company and Eontec, entered into a license agreement pursuant to which the Company and Eontec entered into a cross-license of their respective technologies. Eontec is a publicly held Hong Kong corporation of which Professor Li is the Chairman and majority shareholder. As of September 30, 2016, Professor Li is a greater-than-5% beneficial owner of the Company. Services procured from Eontec were $58 and $68 during the three and nine month periods ended September 30, 2016, respectively.

17

LIQUIDMETAL TECHNOLOGIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
For the Nine Months Ended September 30, 2016 and 2015

(numbers in thousands, except share and per share data)

(unaudited)

19. Subsequent Event

2016 Purchase Agreement

On October 26, 2016, the Company issued and sold to the Investor an aggregate of 300,000,000 shares of Company’s common stock for an aggregate purchase price of $55,000, comprised of 200,000,000 shares at a price of $0.15 per share and 100,000,000 shares at a price of $0.25 per share. As a result of this closing, the Investor has completed its entire investment in the Company contemplated by the 2016 Purchase Agreement.

Stock Issuance Costs

On November 8, 2016, the Company reached a settlement with respect to any and all amounts due under an investment banking services agreement that resulted in the payment of success fees related to previously executed equity sales. This settlement, in the amount of $750, is deemed to terminate the investment banking services agreement, in all respects, as of this settlement date. Such amounts have been reflected as an accrued liability as of September 30, 2016 and reflected as stock issuance costs as a reduction to additional paid in capital.

18

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

This management’s discussion and analysis should be read in conjunction with the consolidated financial statements and notes included elsewhere in this Quarterly Report on Form 10-Q. All amounts described in this section are in thousands, except percentages, periods of time, and share and per share data.

This management’s discussion and analysis, as well as other sections of this Quarterly Report on Form 10-Q, may contain “forward-looking statements” that involve risks and uncertainties, including statements regarding our plans, future events, objectives, expectations, estimates, forecasts, assumptions, or projections. Any statement that is not a statement of historical fact is a forward-looking statement, and in some cases, words such as “believe,” “estimate,” “project,” “expect,” “intend,” “may,” “anticipate,” “plan,” “seek,” and similar words or expressions identify forward-looking statements. These statements involve risks and uncertainties that could cause actual outcomes and results to differ materially from the anticipated outcomes or results, and undue reliance should not be placed on these statements. These risks and uncertainties include, but are not limited to, the matters discussed under the heading “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015 and other risks and uncertainties discussed in other filings made with the Securities and Exchange Commission (including risks described in subsequent reports on Form 10-Q and Form 8-K and other filings). We disclaim any intention or obligation, other than as required by applicable law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Overview

We are a materials technology company that develops and commercializes products made from amorphous alloys. Our Liquidmetal® family of alloys consists of a variety of proprietary bulk alloys and composites that utilize the advantages offered by amorphous alloy technology. We design, develop and sell custom products and components from bulk amorphous alloys to customers in various industries. We also partner with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products.

Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that we believe will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. Our alloys and the injection molding technology we employ result in components that exhibit: exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. Interestingly, all of these characteristics are achievable from the molding process, so design engineers do not have to select specific alloys to achieve one or more of the characteristics as is the case with crystalline materials. We believe these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, we believe these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.

Our revenues are derived from i) selling our bulk amorphous alloy custom products and components for applications which include, but are not limited to, non-consumer electronic devices, medical products, automotive components, and sports and leisure goods; ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development; iii) product licensing and royalty revenue; and iv) research and development revenue. We expect that these sources of revenue will continue to significantly change the character of our revenue mix.

Our cost of sales consists primarily of the costs of manufacturing, which include raw alloy and internal labor required to operate our on-site production cell. Selling, general, and administrative expenses currently consist primarily of salaries and related benefits, travel, consulting and professional fees, depreciation and amortization, insurance, office and administrative expenses, and other expenses related to our operations.

Research and development expenses represent salaries, related benefits expenses, depreciation of research equipment, consulting and contract services, expenses incurred for the design and testing of new processing methods, expenses for the development of sample and prototype products, and other expenses related to the research and development of Liquidmetal bulk alloys. Costs associated with research and development activities are expensed as incurred. We plan to enhance our competitive position by improving our existing technologies and developing advances in amorphous alloy technologies. We believe that our research and development efforts will focus on the discovery of new alloy compositions, the development of improved processing technology, and the identification of new applications for our alloys.

19

Licensing Transactions

Eontec License Agreement

In connection with the 2016 Purchase Agreement (as further described below), on March 10, 2016, the Company and DongGuan Eontec Co., Ltd., a Hong Kong corporation (“Eontec”), entered into a Parallel License Agreement (the “License Agreement”) pursuant to which the Company and Eontec entered into a cross-license of their respective technologies.

The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between the Company and Eontec. In particular, under the License Agreement, the Company granted to Eontec a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to the Company’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of North America and Europe, and Eontec granted to the Company a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of specified countries in Asia. The license granted by the Company to Eontec is exclusive (including to the exclusion to the Company) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, North Korea, Philippines, Singapore, South Korea, Thailand and Vietnam. The license granted by Eontec to the Company is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories.

Apple License Transaction

On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use.

Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property that it developed through February 2012. Subsequently, this obligation was extended to apply to all intellectual property developed through February 2016. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.

Visser Precision Cast, LLC License Transaction

On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing. On May 20, 2014, the Company and Visser entered into a settlement agreement significantly amending the Visser MTA, whereby the Company granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014 (the “Effective Date”). Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date. The license to the Company’s intellectual property developed on or prior to the Effective Date does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement.

With the foregoing revised arrangements, the Company is no longer required to use Visser as its exclusive manufacturer and is free to license other manufacturers on a non-exclusive basis in any industry or geographic market as to which the Company has not previously granted an exclusive license to a third party. Additionally, the settlement amended and restated the two warrants the Company issued to Visser in June 2012 to purchase 15,000,000 shares of the Company’s common stock at an exercise price of $0.22 per share. The amended and restated warrant agreement includes the effect of anti-dilution adjustments and is exercisable for 18,611,079 shares of common stock (increased further to 21,126,522 shares under the anti-dilution provisions of the warrants, see Note 11) at an exercise price of $0.17 per share (further reduced to $0.16 per share under the anti-dilution provisions of the warrants, see Note 11).

Other License Transactions

On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel. On December 6, 2013, the companies entered into an Exclusivity Agreement for a 10 year term whereby the Company agreed, with certain exceptions and limitations, that the Company and its licensees would purchase amorphous alloy injection molding machines exclusively from Engel, and this exclusivity right was granted in exchange for certain royalties to be paid by Engel to the Company based on a percentage of the net sales price of such injection molding machines.

20

The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. The Company owns 79% of the outstanding common stock in Liquidmetal Golf.

In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”). Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets. The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021.

In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches and all third parties (including the Company), but non-exclusive as to Apple, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

Critical Accounting Policies and Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ materially from these estimates under different assumptions or conditions.

We believe that the following accounting policies are the most critical to our consolidated financial statements since these policies require significant judgment or involve complex estimates that are important to the portrayal of our financial condition and operating results:

• Revenue recognition

• Impairment of long-lived assets and definite-lived intangibles

• Deferred tax assets

• Valuation of liability classified warrants and options and embedded derivatives

• Share based compensation

Our Annual Report on Form 10-K for the year ended December 31, 2015 (the “2015 Annual Report”) contains further discussions on our critical accounting policies and estimates.

21

Results of Operations  

Comparison of the three and nine months ended September 30, 2016 and 2015

	For the three months ended September 30,												For the nine months ended September 30,
	2016 (unaudited)						2015 (unaudited)						2016 (unaudited)						2015 (unaudited)
	in 000's			% of Products Revenue			in 000's			% of Products Revenue			in 000's			% of Products Revenue			in 000's			% of Products Revenue
Revenue:
Products	$	154					$	42					$	329					$	80
Licensing and royalties		-						-						27						27
Total revenue		154						42						356						107
Cost of sales		165			107	%		160			381	%		336			102	%		312			390	%
Gross profit (loss)		(11	)		-7	%		(118	)		-281	%		20			6	%		(205	)		-256	%
Selling, marketing, general and administrative		1,679			1090	%		1,763			4198	%		5,461			1660	%		5,506			6883	%
Research and development		548			356	%		491			1169	%		1,730			526	%		1,428			1785	%
Operating loss		(2,238	)					(2,372	)					(7,171	)					(7,139	)
Change in value of warrant liabilities, gain (loss)		563						1,138						(1,885	)					1,326
Change in value of option liabilities, loss		-						-						(2,613	)					-
Loss on contract modification		(2,126	)					-						(2,126	)					-
Interest expense		(1	)					(1	)					(9	)					(1	)
Interest income		-						5						-						19
Net loss	$	(3,802	)				$	(1,230	)				$	(13,804	)				$	(5,795	)

In discussing our results of our operations, we have categorized the specific items of our consolidated statements of operations into various categories to facilitate the understanding of our core business operations. Explanations of each category as well as analyses of specific items contained in that category are discussed below:

Operating revenue and expenses

The “Operating revenue and expenses” category of statements of operations items represent those items that pertain to our core operations in the bulk alloy manufacturing and licensing business as follows:

Revenue. Total revenue increased to $154 for the three months ended September 30, 2016 from $42 for the three months ended September 30, 2015. Total revenue increased to $356 for the nine months ended September 30, 2016 from $107 for the nine months ended September 30, 2015. The increase for both periods was attributable to a higher mix of small scale pre-production orders during 2016 as a result of our continued build out of our on-site manufacturing capabilities.

Cost of sales. Cost of sales was $165, or 107% of products revenue, for the three months ended September 30, 2016, an increase from $160, or 381% of products revenue, for the three months ended September 30, 2015. Cost of sales was $336, or 102% of products revenue, for the nine months ended September 30, 2016, an increase from $312, or 390% of products revenue, for the nine months ended September 30, 2015.The decrease in our cost of sales as a percentage of product revenue for the three and nine months ended September 30, 2016 was primarily attributable to higher costs of production during the 2015 periods as a result of the initial on-set of manufacturing efforts and the scaling of internal processes. The cost to manufacture products and components from our bulk amorphous alloys is variable and differs based on the unique design of each product. Given the continued development and refinement of our manufacturing efforts during the three and nine months ended September 30, 2016, our cost of sales as a percentage of products revenue is not necessarily representative of our future cost percentages and is expected to show continued improvement over time with increases in volume and continuous refinements to our internal processes. When we begin increasing our products revenues with shipments of routine, commercial products and components through our manufacturing facility and/or third party contract manufacturers, we expect our cost of sales percentages to decrease, stabilize and be more predictable.

22

Gross profit (loss). Our gross profit increased to $(11) from $(118) for the three month periods ended September 30, 2016 and 2015, respectively. Our gross profit, as a percentage of products revenue, increased to (7)% from (281)% for the three month periods ended September 30, 2016 and 2015, respectively. Our gross profit increased to $20 from $(205) for the nine month periods ended September 30, 2016 and 2015, respectively. Our gross profit, as a percentage of products revenue, increased to 6% from (256)% for the nine month periods ended September 30, 2016 and 2015, respectively. As discussed above under “Cost of sales”, early pre-production orders are resulting in a higher cost mix, relative to revenue, than would otherwise be incurred in an on-site production environment, with higher volumes and more established operating processes, or through contract manufacturers. As such, our gross profit percentages have fluctuated and may continue to fluctuate based on volume and quoted production prices per unit and may not be representative of our future business. When we begin increasing our products revenues with shipments of routine, commercial products and components through future orders to our manufacturing facility and/or third party contract manufacturers, we expect our gross profit percentages to stabilize, increase and be more predictable.

Selling, marketing, general and administrative. Selling, marketing, general and administrative expenses were $1,679 and $5,461 for the three and nine months ended September 30, 2016, respectively, compared to $1,763 and $5,506 for the three and nine months ended September 30, 2015, respectively. The decrease in expense for both periods was due to lower costs associated with employee compensation, inclusive of stock based compensation.

Research and development. Research and development expenses increased to $548 and $1,730 for the three and nine months ended September 30, 2016, respectively, from $491 and $1,428 for the three and nine months ended September 30, 2015, respectively. The increase in expense was mainly due to additional research projects and additional personnel hired to support our material and process development efforts. We continue to (i) perform research and development of new Liquidmetal alloys and related processing capabilities, (ii) develop new manufacturing techniques, and (iii) contract with consultants to advance the development of Liquidmetal alloys and related production processes.

Operating loss. Operating loss was $2,238 and $7,171 for the three and nine months ended September 30, 2016, respectively. This compares to $2,372 and $7,139 for the three and nine months ended September 30, 2015, respectively. Fluctuations in our operating loss are primarily attributable to variations in operating expenses, as discussed above.

We continue to invest in our technology infrastructure to expedite the adoption of our technology, but we have experienced long sales lead times for customer adoption of our technology. Until that time where we can either (i) increase our revenues with shipments of routine, commercial products and components through a combination of our manufacturing center or third party contract manufacturers or (ii) obtain significant licensing revenues, we expect to continue to have operating losses for the foreseeable future.

Non-operational expenses

Our statement of operations contains various, significant items that are non-operational in nature. These categories of expenses may have significant gains and losses based on the volatility of our stock price as follows:

Change in value of warrant liabilities. The change in value of warrant liabilities was a non-cash gain (loss) of $563 and $(1,885) for the three and nine months ended September 30, 2016, respectively. This compares to a non-cash gain of $1,138 and $1,326 for the three and nine months ended September 30, 2015, respectively. These adjustments result from periodic valuation adjustments related to fluctuations in our stock price, and other inputs, for warrants issued in connection with the Visser MTA, the July 2012 Private Placement, and the 2016 Purchase Agreement. Changes in the value of our warrants are non-cash and do not affect the core operations of our business or liquidity.

Change in value of option liabilities. The change in value of option liabilities was a non-cash loss of $0 and $2,613 for the three and nine months ended September 30, 2016, respectively. This compares to $0 for the corresponding three and nine month periods ended September 30, 2015. These adjustments result from periodic valuation adjustments related to fluctuations in our stock price, and other inputs, for written call options issued in connection with the 2016 Purchase Agreement. Changes in the value of option liabilities are non-cash and do not affect the core operations of our business or liquidity.

Loss on contract modification. As a result of the amendment to the 2016 Purchase Agreement, we incurred an additional $2,126 of expense relating to the extension of the exercise term for the written call options under the 2016 Purchase Agreement. Such expense was recorded directly to additional paid in capital.

Interest expense. Interest expense relates to interest incurred under our line of credit agreement. Such amounts were $1 and $9 for the three and nine months ended September 30, 2016, respectively. This compares to $1 and $1 for the three and nine months ended September 30, 2015, respectively.

Interest income. Interest income relates to interest earned from our cash deposits for the respective periods. Such amounts were $0 and $0 for the three and nine months ended September 30, 2016, respectively. This compares to $5 and $19 for the three and nine months ended September 30, 2015, respectively.

23

Liquidity and Capital Resources

Cash used in operating activities

Cash used in operating activities totaled $6.0 million and $5.3 million for the nine months ended September 30, 2016 and 2015, respectively. The cash was primarily used to fund operating expenses related to our business and product development efforts.

Cash provided by (used in) investing activities

Cash provided by (used in) investing activities totaled $1.9 million and $(2.7) million for the nine months ended September 30, 2016 and 2015, respectively. Investing outflows primarily consist of capital expenditures to support our manufacturing efforts. Also included in investing cash flows are changes in restricted cash to support line of credit collateral requirements of which $2.0 million was recorded as an in-flow during the nine months ended September 30, 2016 and $2.0 million was recorded as an outflow during the nine months ended September 30, 2015.

Cash provided by financing activities

Cash provided by financing activities totaled $7.7 million and $2.3 for the nine months ended September 30, 2016 and 2015, respectively. Cash provided by financing activities is comprised of cash received for the issuance of shares under the 2016 Purchase Agreement during 2016 and equity sales under the 2014 Purchase Agreement during 2015. Also included were funds received under our line of credit facility and subsequent paydowns of the same facility.

Financing arrangements and outlook

On March 10, 2016, we entered into a Securities Purchase Agreement (the “2016 Purchase Agreement”) with Liquidmetal Technology Limited, a Hong Kong company (the “Investor”), providing for the purchase by the Investor of up to 405,000,000 shares of our common stock for an aggregate purchase price of $63.4 million.

The 2016 Purchase Agreement provides that the Investor is obligated to purchase up to 405,000,000 shares of our common stock in multiple closings, with the Investor having purchased 105,000,000 shares at an aggregate purchase price of $8.4 million (or $0.08 per share) at the initial closing on March 10, 2016, with the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55.0 million closing on October 26, 2016. As a result of these purchases, the Investor has completed its entire investment contemplated by the 2016 Purchase Agreement.

We have a relatively limited history of producing bulk amorphous alloy products and components on a mass-production scale. Furthermore, the ability of future contract manufacturers to produce our products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of our control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. These factors have required that we engage in equity sales under various stock purchase agreements to support our operations and strategic initiatives. Uncertainty as to the outcome of these factors has previously raised substantial doubt about our ability to continue as a going concern. Following the closing of the remaining funding under the 2016 Purchase Agreement, we anticipate that our current capital resources, when considering expected losses from operations, will be sufficient to fund our operations for the foreseeable future.

Off Balance Sheet Arrangements 

As of September 30, 2016, we did not have any off-balance sheet arrangements.

Item 3 – Quantitative and Qualitative Disclosures about Market Risk

None.

Item 4 – Controls and Procedures

Evaluation of Disclosure Controls and Procedures. 

Under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of September 30, 2016. Based on their evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2016.

24

Changes in Internal Control over Financial Reporting.

There were no changes in our internal control over financial reporting (as that term is defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2016 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

25

PART II

OTHER INFORMATION

Item 1 – Legal Proceedings

There have been no significant developments with respect to legal proceedings specifically affecting Liquidmetal Technologies, Inc. or its subsidiaries since the filing of the 2015 Annual Report.

Item 1A – Risk Factors

For a detailed discussion of the risk factors that should be understood by any investor contemplating an investment in our stock, please refer to Part I, Item 1A “Risk Factors” in the 2015 Annual Report. There have been no material changes from the risk factors previously disclosed in Part I, Item 1A “Risk Factors” in the 2015 Annual Report.

Item 2 – Unregistered Sales of Equity Securities and Use of Proceeds

During the period covered by this Quarterly Report on Form 10-Q, we did not issue or sell any unregistered equity securities, other than as reported in the Company’s Current Reports on Form 8-K filed with the SEC on March 14, 2016 and October 27, 2016 with respect to the 2016 Purchase Agreement.

Item 3 – Defaults Upon Senior Securities

None.

Item 4 – Mine Safety Disclosures

None.

Item 5 – Other Information

None.

26

Item 6 – Exhibits

The following documents are filed as exhibits to this Report:

Exhibit Number	Description of Document
10.1	Amendment to Securities Purchase Agreement, dated August 11, 2016, between Liquidmetal Technologies, Inc. and Liquidmetal Technology Limited (incorporated by reference from Exhibit 10.1 to the Form 8-K filed on August 17, 2016).
31.1	Certification of Principal Executive Officer, Thomas Steipp, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Principal Financial Officer, Tony Chung, as required by Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer, Thomas Steipp, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer, Tony Chung, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.1	The following financial statements from Liquidmetal Technologies, Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 (unaudited), formatted in XBRL: (i) Consolidated Balance Sheets as of September 30, 2016 and December 31, 2015, (ii) Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2016 and 2015, (iii) Consolidated Statement of Shareholders’ Equity for the nine months ended September 30, 2016, (iv) Consolidated Statements of Cash Flows for the nine months ended September 30, 2016 and 2015, and (v) Notes to Consolidated Financial Statements.

27

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	LIQUIDMETAL TECHNOLOGIES, INC.
	(Registrant)
Date: November 14, 2016	/s/ Thomas Steipp
	Thomas Steipp
	President and Chief Executive Officer
	(Principal Executive Officer)
Date: November 14, 2016	/s/ Tony Chung
	Tony Chung
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

 28

EX-31.1

Exhibit 31.1

certificationS

I, Thomas Steipp, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Liquidmetal Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)     Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a)     All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2016	/s/ Thomas Steipp
	Thomas Steipp
	President and Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Tony Chung, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Liquidmetal Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2016	/s/ Tony Chung
	Tony Chung
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

WRITTEN STATEMENT OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. 1350

Solely for the purposes of complying with 18 U.S.C. 1350, I, the undersigned Chief Executive Officer of Liquidmetal Technologies, Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Thomas Steipp                                      

Thomas Steipp, President and Chief Executive Officer

November 14, 2016

EX-32.2

Exhibit 32.2

WRITTEN STATEMENT OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. 1350

Solely for the purposes of complying with 18 U.S.C. 1350, I, the undersigned Chief Financial Officer of Liquidmetal Technologies, Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Tony Chung                                                                             

Tony Chung, Chief Financial Officer

November 14, 2016

XML

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Nov. 11, 2016
Document Information [Line Items]
Entity Registrant Name	LIQUIDMETAL TECHNOLOGIES INC
Entity Central Index Key	0001141240
Trading Symbol	lqmt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		882,481,151
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Warrant [Member]
Current liabilities:
Included in current liabilities	$ 1,255,000
Long-term liabilities:
Included in long-term liabilities	1,449,000
Call Option [Member]
Current liabilities:
Included in current liabilities	0	0
Cash	6,402,000	2,773,000
Restricted cash	5,000	2,008,000
Trade accounts receivable, net of allowance for doubtful accounts	17,000	30,000
Inventory	227,000	83,000
Prepaid expenses and other current assets	452,000	408,000
Total current assets	7,103,000	5,302,000
Property and equipment, net	1,134,000	1,370,000
Patents and trademarks, net	518,000	570,000
Other assets	36,000	31,000
Total assets	8,791,000	7,273,000
Short-term debt		700,000
Accounts payable	216,000	250,000
Accrued liabilities	1,695,000	947,000
Deferred revenue	13,000	77,000
Total current liabilities	3,179,000	1,974,000
Long-term liabilities:
Included in long-term liabilities	1,449,000	59,000
Other long-term liabilities	856,000	856,000
Total liabilities	5,484,000	2,889,000
Shareholders' equity:
Preferred Stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively
Common stock, $0.001 par value; 1,100,000,000 shares authorized; 582,332,818 and 477,149,485 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively.	582,000	477,000
Warrants	18,179,000	18,179,000
Additional paid-in capital	216,357,000	203,735,000
Accumulated deficit	(231,743,000)	(217,945,000)
Non-controlling interest in subsidiary	(68,000)	(62,000)
Total shareholders' equity	3,307,000	4,384,000
Total liabilities and shareholders' equity	$ 8,791,000	$ 7,273,000

XML

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,100,000,000	1,100,000,000
Common stock, shares issued (in shares)	582,332,818	477,149,485
Common stock, shares outstanding (in shares)	582,332,818	477,149,485

XML

Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Revenue
Products	$ 154,000	$ 42,000	$ 329,000	$ 80,000
Licensing and royalties			27,000	27,000
Total revenue	154,000	42,000	356,000	107,000
Cost of sales	165,000	160,000	336,000	312,000
Gross profit (loss)	(11,000)	(118,000)	20,000	(205,000)
Operating expenses
Selling, marketing, general and administrative	1,679,000	1,763,000	5,461,000	5,506,000
Research and development	548,000	491,000	1,730,000	1,428,000
Total operating expenses	2,227,000	2,254,000	7,191,000	6,934,000
Operating loss	(2,238,000)	(2,372,000)	(7,171,000)	(7,139,000)
Change in value of warrant liabilities, gain (loss)	563,000	1,138,000	(1,885,000)	1,326,000
Change in value of option liabilities, loss			(2,613,000)
Loss on contract modification	(2,126,000)		(2,126,000)
Interest expense	(1,000)	(1,000)	(9,000)	(1,000)
Interest income	0	5,000		19,000
Net loss and comprehensive loss	(3,802,000)	(1,230,000)	(13,804,000)	(5,795,000)
Net loss attributable to non-controlling interest	2,000	2,000	6,000	6,000
Net loss and comprehensive loss attributable to Liquidmetal Technologies shareholders	$ (3,800,000)	$ (1,228,000)	$ (13,798,000)	$ (5,789,000)
Net loss per common share attributable to Liquidmetal Technologies shareholders, basic and diluted (in dollars per share)	$ (0.01)	$ 0	$ (0.02)	$ (0.01)
Number of weighted average shares - basic and diluted (in shares)	582,332,818	475,816,152	558,918,003	468,890,226

XML

Consolidated Statement of Shareholders' Equity (Unaudited) - 9 months ended Sep. 30, 2016 - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Warrant [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2015		477,149,485
Balance at Dec. 31, 2015		$ 477	$ 18,179	$ 203,735	$ (217,945)	$ (62)	$ 4,384
Common stock issuance, net of issuance costs (in shares)		105,000,000
Common stock issuance, net of issuance costs		$ 105		6,274			6,379
Stock option exercises (in shares)		183,333
Stock option exercises				15			15
Stock-based compensation				1,083			1,083
Written call options				3,124			3,124
Loss on contract modification				2,126			2,126
Net loss					(13,798)	(6)	(13,804)
Balance (in shares) at Sep. 30, 2016		582,332,818
Balance at Sep. 30, 2016		$ 582	$ 18,179	$ 216,357	$ (231,743)	$ (68)	$ 3,307

XML

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Operating activities:
Net loss	$ (13,804,000)	$ (5,795,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	415,000	374,000
Bad debt expense		19,000
Stock-based compensation	1,083,000	1,035,000
Loss on contract modification	2,126,000
Restricted stock compensation issued to officer		182,000
Change in value of warrant liabilities, loss	1,885,000	(1,326,000)
Loss from change in value of option liabilities	2,613,000
Changes in operating assets and liabilities:
Trade accounts receivable	13,000	44,000
Inventory	(144,000)	(111,000)
Prepaid expenses and other current assets	(44,000)	(17,000)
Other assets	(5,000)
Accounts payable and accrued liabilities	(36,000)	323,000
Deferred revenue	(64,000)	22,000
Net cash used in operating activities	(5,962,000)	(5,250,000)
Investing Activities:
Purchases of property and equipment	(105,000)	(650,000)
Decrease (increase) in restricted cash	2,003,000	(2,006,000)
Investment in patents and trademarks	(22,000)
Net cash provided by (used in) investing activities	1,876,000	(2,656,000)
Financing Activities:
Proceeds from short-term debt		700,000
Repayment of short-term debt	(700,000)
Proceeds from exercise of stock options	15,000	13,000
Proceeds from common stock issuance, net of issuance costs	8,400,000	1,568,000
Net cash provided by financing activities	7,715,000	2,281,000
Net increase (decrease) in cash	3,629,000	(5,625,000)
Cash at beginning of period	2,773,000	10,009,000
Cash at end of period	6,402,000	4,384,000
Supplemental Schedule of Non-Cash Investing and Financing Activities:
Accrued stock issuance costs	$ (750,000)

XML

Note 1 - Description of Business

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Business Description and Basis of Presentation [Text Block]

1. Description of Business

Liquidmetal Technologies, Inc. (the “Company”) is a materials technology and manufacturing company that develops and commercializes products made from amorphous alloys. The Company’s family of alloys consists of a variety of bulk alloys and composites that utilizes the advantages offered by amorphous alloys technology. The Company designs, develops, manufactures and sells custom products and components from bulk amorphous alloys to customers in a wide range of industries. The Company also partners with third-party manufacturers and licensees to develop and commercialize Liquidmetal alloy products.

Amorphous alloys are, in general, unique materials that are distinguished by their ability to retain a random atomic structure when they solidify, in contrast to the crystalline atomic structure that forms in other metals and alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys that possess a combination of performance, processing, and potential cost advantages that the Company believes will make them preferable to other materials in a variety of applications. The amorphous atomic structure of bulk alloys enables them to overcome certain performance limitations caused by inherent weaknesses in crystalline atomic structures, thus facilitating performance and processing characteristics superior in many ways to those of their crystalline counterparts. The Company’s alloys and the injection molding technology it employs result in components that exhibit: exceptional dimensional control and repeatability that rivals precision machining, excellent corrosion resistance, brilliant surface finish, high strength, high hardness, high elastic limit, alloys that are non-magnetic, and the ability to form complex shapes common to the injection molding of plastics. Interestingly, all of these characteristics are achievable from the molding process, so design engineers do not have to select specific alloys to achieve one or more of the characteristics as is the case with crystalline materials. The Company believes these advantages could result in Liquidmetal alloys supplanting high-performance alloys, such as titanium and stainless steel, and other incumbent materials in a wide variety of applications. Moreover, the Company believes these advantages could enable the introduction of entirely new products and applications that are not possible or commercially viable with other materials.

The Company’s revenues are derived from i) selling bulk amorphous alloy custom products and components for applications which include, but are not limited to, non-consumer electronic devices, medical products, automotive components, and sports and leisure goods, ii) selling tooling and prototype parts such as demonstration parts and test samples for customers with products in development, iii) product licensing and royalty revenue, and iv) research and development revenue. The Company expects that these sources of revenue will continue to significantly change the character of the Company’s revenue mix.

XML

Note 2 - Basis of Presentation and Recent Accounting Pronouncements

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Basis of Presentation and Significant Accounting Policies [Text Block]

2

.

Basis of Presentation and Recent Accounting Pronouncements

The accompanying unaudited interim consolidated financial statements as of and for the three and nine months ended September 30, 2016 and September 30, 2015 have been prepared in accordance with accounting principles generally accepted in the United States of America (“generally accepted accounting principles”) for interim financial information and in accordance with the instructions to Form 10-Q. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring accruals) considered necessary for a fair presentation have been included. All intercompany balances and transactions have been eliminated in consolidation. Operating results for the three and nine months ended September 30, 2016 are not necessarily indicative of the results that may be expected for any future periods or the year ending December 31, 2016. The accompanying unaudited consolidated financial statements should be read in conjunction with the Company's 2015 Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 7, 2016.

Revenue Recognition

The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of bulk amorphous alloy custom products and components, the tooling associated with production and prototyping projects, and licensing and royalty fees for the use of the Liquidmetal brand and certified Liquidmetal bulk amorphous alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.

License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.

Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

Fair Value

Measurements

The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash, restricted cash, and short-term debt approximate their carrying value due to their short maturities.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

Level 1 — Quoted prices in active markets for identical assets or liabilities;

Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level 2 measurement inputs. These instruments are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing the accounting for certain financial instruments with characteristics of both liabilities and equity and derivative accounting. The fair value of such instruments is estimated using the Black-Scholes option pricing model. Due to the presence of certain anti-dilution and exercise price reset provisions

, such instruments are required to be classified as liabilities (see Note 11).

As of September 30, 2016, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (current)		1,255		-		1,255		-
Warrant liabilities (long-term)		1,449		-		1,449		-

As of December 31, 2015, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (long-term)		59		-		59		-

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued an accounting standards update which modifies the accounting for leasing arrangements, particularly those arrangements classified as operating leases. This update will require entities to recognize the assets and liabilities arising from operating leases on the balance sheet. This guidance is effective for fiscal and interim periods beginning after December 15, 2018 and is required to be applied retrospectively to all leasing arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements.

Stock-Based Compensation

In March 2016, the FASB issued an accounting standards update which simplifies the accounting for share-based payment transactions, inclusive of income tax accounting and disclosure considerations. This guidance is effective for fiscal and interim periods beginning after December 15, 2016 and is required to be applied retrospectively to all impacted share-based payment arrangements. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Revenue from Contracts with Customers

In May 2014, the FASB issued an accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective for fiscal and interim periods beginning after December 15, 2017 and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements.

Ability to Continue as a Going Concern

In August 2014, the FASB issued an accounting standards update which requires an assessment of an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently addressed by U.S. auditing standards. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Inventory

In July 2015, the FASB issued an accounting standards update which modifies the requirements for measuring the value of inventory on a periodic basis. The new requirement will be to measure inventory at the lower of cost or net realizable value. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

XML

Note 3 - Significant Transactions

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Significant Transactions [Text Block]

3

.

Significant Transactions

2016 Purchase Agreement

On March 10, 2016, the Company entered into a Securities Purchase Agreement (the “2016 Purchase Agreement”) with Liquidmetal Technology Limited, a Hong Kong company (the “Investor”), providing for the purchase by the Investor of up to 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400.

The 2016 Purchase Agreement provided that the Investor is obligated to purchase up to 405,000,000 shares of the Company’s common stock in multiple closings, with the Investor having purchased 105,000,000 shares at an aggregate purchase price of $8,400 (or $0.08 per share) at the initial closing on March 10, 2016. The 2016 Purchase Agreement provided that the Investor will purchase the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55,000 after the satisfaction of certain conditions, including Company shareholder approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation increasing the Company’s authorized number of shares of common stock from 700,000,000 to 1,100,000,000 (the “Charter Amendment”).

In addition to the shares issuable under the 2016 Purchase Agreement, the Company also issued to the Investor a warrant to acquire 10,066,809 shares of common stock of the Company at an exercise price of $0.07 per share. The warrant vests in increments on each closing date under the 2016 Purchase Agreement for a number of warrant shares that is proportionate to the amount of shares purchased under the 2016 Purchase Agreement on such closing date (with 2,609,913 warrant shares having initially vested on March 10, 2016 and the remaining 7,456,896 warrant shares vesting on October 26, 2016). The warrant will expire on the 10th anniversary of its issuance date.

The 2016 Purchase Agreement also provided that the Investor would have the right to designate one individual to serve on the Company’s Board of Directors. Once the Investor purchases the remaining 300,000,000 shares of common stock under the 2016 Purchase Agreement, the Investor would thereafter have the right to designate an additional two individuals to serve on the Company’s Board of Directors (such that the Investor would have designation rights with respect to three of the seven members of the Company’s Board of Directors, with one such member serving as Chairman). The 2016 Purchase Agreement also provided that, with certain limited exceptions, if the Company issues any shares of common stock at any time through the 5th anniversary of the Purchase Agreement, the Investor will have a preemptive right to subscribe for and to purchase at the same price per share (or at market price, in the case of issuance of shares pursuant to stock options) the number of shares necessary to maintain its ownership percentage of Company-issued shares of common stock.

On May 19, 2016, the Company’s shareholders approved the Charter Amendment, thereby obligating the Investor to purchase the remaining 300,000,000 shares of the Company’s common stock for the aggregate purchase price of $55,000. 

On October 26, 2016, the Company issued and sold to the Investor an aggregate of 300,000,000 shares of Company’s common stock for an aggregate purchase price of $55,000, comprised of 200,000,000 shares at a price of $0.15 per share and 100,000,000 shares at a price of $0.25 per share. As a result of this closing, the Investor has completed its entire investment in the Company contemplated by the 2016 Purchase Agreement.

Eontec License Agreement

In connection with the 2016 Purchase Agreement and also on March 10, 2016, the Company and DongGuan Eontec Co., Ltd., a Hong Kong corporation (“Eontec”), entered into a Parallel License Agreement (the “License Agreement”) pursuant to which the Company and Eontec entered into a cross-license of their respective technologies.

The License Agreement provides for the cross-license of certain patents, technical information, and trademarks between the Company and Eontec. In particular, under the License Agreement, the Company granted to Eontec a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to the Company’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of North America and Europe, and Eontec granted to the Company a paid-up, royalty-free, perpetual license (or sublicense, as the case may be) to Eontec’s patents and related technical information to make, have made, use, offer to sell, sell, export and import products in certain geographic areas outside of specified countries in Asia. The license granted by the Company to Eontec is exclusive (including to the exclusion to the Company) in the countries of Brunei, Cambodia, China (P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar, North Korea, Philippines, Singapore, South Korea, Thailand and Vietnam. The license granted by Eontec to the Company is exclusive (including to the exclusion of Eontec) in North America and Europe. The cross-licenses are non-exclusive in geographic areas outside of the foregoing exclusive territories.

2014

Purchase Agreement

On August 20, 2014, the Company entered into a common stock purchase agreement (“2014 Purchase Agreement”) with Aspire Capital Fund LLC (“Aspire Capital”), which provided that, upon the terms and subject to the conditions and limitations set forth therein, Aspire Capital would be committed to purchase up to an aggregate of $30,000 worth of the Company’s common stock, $0.001 par value, over the 36

-month term of the 2014 Purchase Agreement.

On March 9, 2016, the Company terminated the 2014 Purchase Agreement. As of the date of termination, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share.

Line of Credit Facility

In February 2015, the Company entered into a $2,000 line of credit facility, with a fixed interest rate of 2.1%, which originally matured on February 13, 2016. The facility was extended through August 25, 2016, with reductions in available borrowings and associated collateral requirements to $1,000. On August 26, 2016, the Company fully repaid all outstanding principal and accrued interest balances due under the facility. As of such date, all collateral to the facility was released. Interest expense applicable to these borrowings was $1 and $9 for the three and nine months ended September 30, 2016, respectively, and $1 and $1 for the corresponding three and nine month periods ended September 30, 2015, respectively.

Apple License Transaction

On August 5, 2010, the Company entered into a license transaction with Apple Inc. (“Apple”) pursuant to which (i) the Company contributed substantially all of its intellectual property assets to a newly organized special-purpose, wholly-owned subsidiary, called Crucible Intellectual Property, LLC (“CIP”), (ii) CIP granted to Apple a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in the field of consumer electronic products, as defined in the license agreement, in exchange for a license fee, and (iii) CIP granted back to the Company a perpetual, worldwide, fully-paid, exclusive license to commercialize such intellectual property in all other fields of use. Additionally, in connection with the license transaction, Apple required the Company to complete a statement of work related to the exchange of Liquidmetal intellectual property information. The Company recognized a portion of the one-time license fee upon receipt of the initial payment and completion of the foregoing requirements under the license transaction. The remaining portion of the one-time license fee was recognized at the completion of the required statement of work.

Under the agreements relating to the license transaction with Apple, the Company was obligated to contribute, to CIP, all intellectual property that it developed through February 2012. Subsequently, this obligation was extended to apply to all intellectual property developed through February 2016. The Company is also obligated to maintain certain limited liability company formalities with respect to CIP at all times after the closing of the license transaction.

Visser Precision Cast, LLC License Agreement

On June 1, 2012, the Company entered into a Master Transaction Agreement (the “Visser MTA”) with Visser Precision Cast, LLC (“Visser”) relating to a strategic transaction for manufacturing services and financing. On May 20, 2014, the Company and Visser entered into a settlement agreement significantly amending the Visser MTA, whereby the Company granted to Visser a fully paid-up, royalty-free, irrevocable, perpetual, worldwide, non-transferable, nonexclusive sublicense to all of the Company’s intellectual property developed on or prior to May 20, 2014 (the “Effective Date”). Visser does not have any rights, now or in the future, to intellectual property of the Company developed after the Effective Date. The license to the Company’s intellectual property developed on or prior to the Effective Date does not include the right to use the “Liquidmetal” trademark or any of the Company’s other trademarks, except in certain defined situations, as set forth in the amended and restated agreement.

With the foregoing revised arrangements, the Company is no longer required to use Visser as its exclusive manufacturer and is free to license other manufacturers on a non-exclusive basis in any industry or geographic market as to which the Company has not previously granted an exclusive license to a third party. Additionally, the settlement amended and restated the two warrants the Company issued to Visser in June 2012 to purchase 15,000,000 shares of the Company’s common stock at an exercise price of $0.22 per share. The amended and restated warrant agreement includes the effect of anti-dilution adjustments and is exercisable for 18,611,079 shares of common stock (increased further to 21,126,522 shares under the anti-dilution provisions of the warrants, see Note 11) at an exercise price of $0.17 per share (further reduced to $0.16 per share under the anti-dilution provisions of the warrants, see Note 11).

Other License Transactions

On January 31, 2012, the Company entered into a Supply and License Agreement for a five year term with Engel Austria Gmbh (“Engel”) whereby Engel was granted a non-exclusive license to manufacture and sell injection molding machines to the Company’s licensees. Since that time, the Company and Engel have agreed on an injection molding machine configuration that can be commercially supplied and supported by Engel.  On December 6, 2013, the companies entered into an Exclusivity Agreement for a 10 year term whereby the Company agreed, with certain exceptions and limitations, that the Company and its licensees would purchase amorphous alloy injection molding machines exclusively from Engel, and this exclusivity right was granted in exchange for certain royalties to be paid by Engel to the Company based on a percentage of the net sales price of such injection molding machines.

The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. This right and license is set forth in an intercompany license agreement between Liquidmetal Technologies and Liquidmetal Golf. This license agreement provides that Liquidmetal Golf has a perpetual and exclusive license to use Liquidmetal alloy technology for the purpose of manufacturing, marketing, and selling golf club components and other products used in the sport of golf. The Company owns 79% of the outstanding common stock of Liquidmetal Golf.

In June 2003, the Company entered into an exclusive license agreement with LLPG, Inc. (“LLPG”).  Under the terms of the agreement, LLPG has the exclusive right to commercialize Liquidmetal alloys, particularly precious-metal based compositions, in jewelry and high-end luxury product markets.  The Company, in turn, will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by LLPG. The exclusive license agreement with LLPG expires on December 31, 2021.

In March 2009, the Company entered into a license agreement with Swatch Group, Ltd. (“Swatch”) under which Swatch was granted a non-exclusive license to the Company’s technology to produce and market watches and certain other luxury products. In March 2011, this license agreement was amended to grant Swatch exclusive rights as to watches and all third parties (including the Company), but non-exclusive as to Apple, and the Company’s license agreement with LLPG was simultaneously amended to exclude watches from LLPG’s rights. The Company will receive royalty payments over the life of the contract on all Liquidmetal products produced and sold by Swatch. The license agreement with Swatch will expire on the expiration date of the last licensed patent.

XML

Note 4 - Liquidity and Capital Resources

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Liquidity and Capital Resources [Text Block]

4

. Liquidity

and

Capital Resources

For the nine months ended September 30, 2016, the Company’s cash used in operations was $5,962, cash flows from investing activities were $1,876, primarily due to reductions in restricted cash as a result of collateral requirement reductions, and cash provided by financing activities was $7,715 due to cash received from equity sales under the 2016 Purchase Agreement and the exercise of stock options. As of September 30, 2016, the Company’s cash and restricted cash balance was $6,407, which consisted of $6,402 of cash and $5 of short-term restricted cash.

On March 10, 2016, the Company entered into the 2016 Purchase Agreement providing for the purchase by the Investor of up to 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400.

The 2016 Purchase Agreement provides that the Investor is obligated to purchase up to 405,000,000 shares of the Company’s common stock in multiple closings, with the Investor having purchased 105,000,000 shares at an aggregate purchase price of $8,400 (or $0.08 per share) at the initial closing on March 10, 2016, with the remaining 200,000,000 shares at $0.15 per share and 100,000,000 shares at $0.25 per share for an aggregate purchase price of $55,000 closing on October 26, 2016 (see Note 3).

The Company has a relatively limited history of producing bulk amorphous alloy products and components on a mass-production scale. Furthermore, the ability of future contract manufacturers to produce the Company’s products in desired quantities and at commercially reasonable prices is uncertain and is dependent on a variety of factors that are outside of the Company’s control, including the nature and design of the component, the customer’s specifications, and required delivery timelines. These factors have required that the Company engage in equity sales under various stock purchase agreements to support its operations and strategic initiatives. Uncertainty as to the outcome of these factors has previously raised substantial doubt about the Company’s ability to continue as a going concern. Following the closing of the remaining funding under the 2016 Purchase Agreement, the Company anticipates that its current capital resources, when considering expected losses from operations, will be sufficient to fund the Company’s operations for the foreseeable future.

XML

Note 5 - Inventory

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Inventory Disclosure [Text Block]

5

.

Inventory

Inventory totaled $227 and $83 as of September 30, 2016 and December 31, 2015, respectively, and primarily consisted of raw alloy and finished goods inventory to satisfy future customer orders. Inventory is stated at the lower of weighted-average cost or market.

XML

Note 6 - Prepaid Expenses and Other Current Assets

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Prepaid Expenses and Other Current Assets [Text Block]

6

.

P

repaid Expenses and Other Current Assets

Prepaid expenses and other current assets totaled $452 and $408 as of September 30, 2016 and December 31, 2015, respectively, and primarily consisted of prepaid invoices and insurance premiums that will be recognized as expenses at a timing consistent with when the associated services are provided.

XML

Note 7 - Patents and Trademarks, Net

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Intangible Assets Disclosure [Text Block]

7

.

Patents and T

rademarks, net

Net patents and trademarks totaled $518 and $570 as of September 30, 2016 and December 31, 2015, respectively, and primarily consisted of purchased patent rights and internally developed patents.

Purchased patent rights represent the exclusive right to commercialize the bulk amorphous alloy and other amorphous alloy technology acquired from California Institute of Technology (“Caltech”), through a license agreement with Caltech and other institutions. All fees and other amounts payable by the Company for these rights and licenses have been paid or accrued in full, and no further royalties, license fees or other amounts will be payable in the future under the license agreement.

In addition to the purchased and licensed patents, the Company has internally developed patents. Internally developed patents include legal and registration costs incurred to obtain the respective patents. The Company currently holds various patents and numerous pending patent applications in the United States, as well as numerous foreign counterparts to these patents outside of the United States.

The Company amortizes capitalized patents and trademarks over an average of 10 to 17 year periods. Amortization expense for patents and trademarks was $25 and $74 for the three and nine month periods ended September 30, 2016, respectively. This compares to $24 and $74 for the three and nine month periods ended September 30, 2015, respectively.

XML

Note 8 - Other Assets

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Other Assets Disclosure [Text Block]

8. Other Assets

Other assets totaled $36 and $31 as of September 30, 2016 and December 31, 2015, respectively, and consisted of deposits under long-term lease agreements.

XML

Note 9 - Accrued Liabilities

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

9

.

Accrued Liabilities

Accrued liabilities totaled $1,695 and $947 as of September 30, 2016 and December 31, 2015, respectively. Included within these totals are the following:

	September 30, 2016		December 31, 2015
Accrued payroll, vacation, and bonuses	$	783	$	766
Accrued stock issuance costs		750		-
Accrued audit fees		71		109
Straight-line rent accruals		91		72
Total		1,695		947

The Company entered into a non-exclusive investment banking engagement agreement with an investment banking firm during 2012 to provide support to the Company in the identification of potential investors for future strategic transactions or financing transactions. The services provided by the investment banking firm did not result in the identification of any practicable investment transactions and the agreement was considered effectively terminated by the Company during 2013, although no formal notice of termination was ever provided by either party. During the three-months ended September 30, 2016, the Company was contacted and advised by a representative of the investment banking firm that the firm did not consider the engagement agreement to be terminated and that amounts raised under the 2013, 2014, and 2016 Purchase Agreements may be subject to success fees stipulated under their investment banking agreement. The firm advised the Company that such success fees would, based on the language of the engagement agreement, be equal to the greater of (i) 5% of the total proceeds received as a result of equity transactions or (ii) $500. To date no formal claims have been filed against the Company. Subsequent to September 30, 2016, the Company reached a settlement with respect to any and all amounts allegedly due under the engagement agreement in the amount of $750. As a result of the settlement, the engagement agreement is deemed to be terminated in all respects as of the settlement date of November 8, 2016. Such amounts have been reflected as an accrued liability as of September 30, 2016 and reflected as stock issuance costs as a reduction to additional paid in capital.

XML

Note 10 - Short-term Debt

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Short-term Debt [Text Block]

10

.

Short-Term Debt

Short-term debt totaled $0 and $700 as of September 30, 2016 and December 31, 2015, respectively, and consisted of borrowings under a line of credit facility, with a fixed interest rate of 2.1%. All borrowings were fully repaid upon maturity of the facility on August 26, 2016. Interest expense related to outstanding borrowings was $1 and $9 for the three and nine months ended September 30, 2016, respectively. This compares to $1 and $1 for the corresponding three and nine month periods ended September 30, 2015.

This credit facility required the Company to maintain collateral for the full amount of the facility. Following maturity of the facility all collateral requirements have been removed.

XML

Note 11 - Warrant Liabilities

9 Months Ended

Sep. 30, 2016

Warrant [Member]

Notes to Financial Statements

Derivatives and Fair Value [Text Block]

11

. Warrant

Liabilities

Pursuant to FASB ASC 815, the Company is required to report the value of certain warrants as a liability at fair value and record the changes in the fair value of the warrant liabilities as a gain or loss in its consolidated statement of operations and comprehensive loss due to the price-based anti-dilution rights of the warrants.

During June 2012, the Company issued warrants to purchase a total of 15,000,000 shares of common stock to Visser under the Visser MTA Agreement (see Note 3). These warrants had an original exercise price of $0.22 per share, expire on June 1, 2017 and were originally valued at $4,260. These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of subsequent issuances of the Company’s common stock, which resulted in anti-dilutive price resets, the exercise price of these warrants was reduced to $0.16 and $0.17 as of September 30, 2016 and December 31, 2015, respectively. In addition, the number of shares to be issued under the warrants as a result of the anti-dilution provision increased to 21,126,522 and 18,937,931 as of September 30, 2016 and December 31, 2015, respectively. As of September 30, 2016, these warrants were valued at $691 under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 0.67 years, (ii) volatility of 72%, (iii) risk-free interest rate of 0.6%, and (iv) dividend rate of 0. The change in fair value for these warrants was a (gain) loss of $(292) and $657 for the three and nine months ended September 30, 2016, respectively.

On July 2, 2012, the Company issued warrants to purchase a total of 18,750,000 shares of common stock in a private placement (the “July 2012 Private Placement”). These warrants have an exercise price of $0.384 per share, expire on July 2, 2017, and were originally valued at $5,053. These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As a result of contractually defined price resets, and issuances under the 2014 and 2016 Purchase Agreements, which resulted in an anti-dilution impact, the exercise price of these warrants was reduced to $0.17 and $0.19 as of September 30, 2016 and December 31, 2015, respectively. As of September 30, 2016 there were warrants to purchase a total of 17,572,000 shares of common stock outstanding, which were valued at $564 under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 0.75 years, (ii) volatility of 76%, (iii) risk-free interest rate of 0.6%, and (iv) dividend rate of 0. The change in fair value for these warrants was a (gain) loss of $(172) and $539 for the three and nine months ended September 30, 2016, respectively.

On March 10, 2016, the Company issued warrants to purchase a total of 10,066,809 shares of common stock as part of the 2016 Purchase Agreement. These warrants have an exercise price of $0.07 per share, expire on March 10, 2026, and were originally valued at $760. These warrants have certain anti-dilution and exercise price reset provisions which qualify the warrants to be classified as a liability under FASB ASC 815. As of September 30, 2016, these warrants were valued at $1,449 under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 9.44 years, (ii) volatility of 120%, (iii) risk-free interest rate of 1.60%, and (iv) dividend rate of 0. The change in fair value for these warrants was a (gain) loss of $(99) and $689 for the three and nine months ended September 30, 2016, respectively.

The following table summarizes the change in the Company’s warrant liabilities as of September 30, 2016:

	Visser MTA Agreement		July 2, 2012 Private Placement		2016 Purchase Agreement		Total
Beginning Balance - December 31, 2015	$	34	$	25	$	-		59
Original valuation- new issuances		-		-		760		760
Change in value of warrant liabilities, loss		657		539		689		1,885
Ending Balance - September 30, 2016	$	691	$	564	$	1,449	$	2,704
Included in current liabilities	$	691	$	564	$	-	$	1,255
Included in long-term liabilities	$	-	$	-	$	1,449	$	1,449

The Company had warrants to purchase 48,765,331 and 36,509,931 shares of common stock outstanding as of September 30, 2016 and December 31, 2015, respectively, which were valued and classified as liabilities under FASB ASC 815.

XML

Note 12 - Option Liabilities

9 Months Ended

Sep. 30, 2016

Call Option [Member]

Notes to Financial Statements

Derivatives and Fair Value [Text Block]

12

.

Option Liabilities

As part of the 2016 Purchase Agreement, executed on March 10, 2016, the Company granted the Investor the right to purchase shares of the Company’s common stock in the future at predetermined prices. These options allow the investor to purchase 200,000,000 shares of the Company’s common stock at a price of $0.15 per share and 100,000,000 shares of the Company’s common stock at a price of $0.25 per share. Given that the number of shares to be issued upon exercise of these options was in excess of the number of shares authorized for issuance, these options were originally required to be classified as liabilities under FASB ASC 815. The 200,000,000 share option and the 100,000,000 share option were initially valued at $489 and $22, respectively. Following the filing of the Charter Amendment, which allowed for adequate authorized shares, these options were revalued as of May 19, 2016 and reclassified to permanent shareholders’ equity. As of May 19, 2016, these written call options were valued at $2,931 and $193, respectively, under the Black-Scholes valuation model utilizing the following assumptions: (i) expected life of 0.25 years, (ii) volatility of 85%, (iii) risk-free interest rate of 0.31%, and (iv) dividend rate of 0. The change in fair value for these options was a loss of $2,442 and $171, respectively, for the nine months ended September 30, 2016.

The following table summarizes the change in the Company’s option liabilities as of September 30, 2016:

	200M Share			100M Share
	Call Option			Call Option			Total
Beginning Balance - December 31, 2015	$	-		$	-			-
Original valuation		489			22			511
Change in value of option liabilities, loss		2,442			171			2,613
Reclassification to shareholders' equity		(2,931	)		(193	)		(3,124	)
Ending Balance - September 30, 2016		-			-			-

On August 11, 2016, the Company and the Investor entered into an amendment to the 2016 Purchase Agreement. Under the amendment, the Company agreed to extend the deadline for the Investor’s purchase of 300,000,000 additional shares of Company common stock under the 2016 Purchase Agreement from the original deadline of August 17, 2016 to a new deadline of December 31, 2016. Other than the extension of the deadline, the amendment does not materially modify the terms of the 2016 Purchase Agreement. As a result of this amendment the Company recorded an additional $2,126 of expense to additional paid in capital. Such amounts are reflected as a loss on contract modification within the consolidated statements of operations.

XML

Note 13 - Other Long-term Liabilities

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Other Liabilities Disclosure [Text Block]

13.

Other Long-

T

erm Liabilities

Other long-term liabilities were $856 as of September 30, 2016 and December 31, 2015, and consisted of long

-term, aged payables to vendors, individuals, and other third parties that have been outstanding for more than 5 years. The Company is in the process of researching and resolving the balances for settlement and/or escheatment in accordance with applicable state law

.

XML

Note 14 - Stock Compensation Plans

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

1

4

.

Stock Compensation Plan

s

Under the Company’s 2002 Equity Incentive Plan (the “2002 Plan”), which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries, the Company granted options to purchase the Company’s common stock.

A total of 10,000,000 shares of the Company’s common stock were available for issuance under the 2002 Plan. The 2002 Plan expired by its terms in April 2012, but remains in effect only with respect to the equity awards that had been granted prior to its expiration. The Company had outstanding grants of options to purchase 507,500 and 822,000 shares of the Company’s common stock as of September 30, 2016 and December 31, 2015, respectively.

On June 28, 2012, the Company adopted its 2012 Equity Incentive Plan, with the approval of the Company’s shareholders, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. All options granted under this plan had exercise prices that were equal to the fair market value on the dates of grant. During the nine months ended September 30, 2016, the Company granted options to purchase 2,000,000 shares of common stock. Under this plan, the Company had outstanding grants of options to purchase 25,746,985 and 25,988,734 shares of the Company’s common stock as of September 30, 2016 and December 31, 2015, respectively.

On January 27, 2015, the Company adopted its 2015 Equity Incentive Plan, which provided for the grant of stock options to officers, employees, consultants and directors of the Company and its subsidiaries. A total of 40,000,000 shares of the Company’s common stock are authorized for issuance under this plan. All options granted under this plan had exercise prices that were equal to the fair market value on the dates of grant. During the nine months ended September 30, 2016, the Company granted options to purchase 14,400,000 shares of common stock. Under this plan, the Company had outstanding grants of options to purchase 27,500,000 and 15,100,000 shares of the Company’s common stock as of September 30, 2016 and December 31, 2015, respectively.

Stock based compensation expense attributable to these plans was $365 and $1,083 for the three and nine months ended September 30, 2016, respectively. This compares to $320 and $1,035 for the three and nine months ended September 30, 2015, respectively.

XML

Note 15 - Shareholders' Equity

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Stockholders' Equity Note Disclosure [Text Block]

1

5

.

Shareholders

’

Equity

Common

S

tock

In June 2012, the Company issued 30,000,000 shares of common stock to Visser in connection with the Visser MTA Agreement (see Note 3).

Pursuant to the terms of the Company’s Senior Convertible Notes due September 1, 2013, which were issued in the July 2012 Private Placement, the Company opted to pay the twelve monthly installment payments prior to the September 1, 2013 maturity date with shares of the Company’s common stock. Upon final settlement, the Company had issued 163,641,547 shares of common stock at a weighted average conversion price of $0.0774, for the twelve installment payments due under the notes, consisting of $12,000 of principal and $680 of interest.

During the year ended December 31, 2013, the holders of the Company’s Series A Preferred Stock converted all of the outstanding 506,936 shares of Series A Preferred Stock into 16,896,070 shares of the Company’s common stock. After giving effect to such conversion, the Company has no shares of preferred stock outstanding.

On February 28, 2013, the Company’s shareholders approved an amendment to the Certificate of Incorporation of the Company increasing the number of authorized shares of common stock from 400 million shares to 500 million shares.

On October 24, 2013, the Company’s shareholders approved an amendment to the Company’s Certificate of Incorporation increasing the number of authorized shares of common stock from 500 million shares to 700 million shares.

In connection with the execution of the 2013 Purchase Agreement, the Company issued to each of the 2013 Investors a pro rata portion of 2,666,667 shares of the Company’s common stock. As of December 31, 2014, the Company had received an aggregate of $16,000 under the 2013 Purchase Agreement through the issuance of 85,355,615 shares of its common stock at a weighted average price of $0.19 per share. On August 22, 2014, the Company voluntarily terminated the 2013 Purchase Agreement, effective August 25, 2014.

On September 9, 2014, an initial registration statement covering 75,000,000 shares issued and issuable pursuant to the 2014 Purchase Agreement was declared effective by the SEC. As of September 30, 2015, the Company had received an aggregate of $1,568 under the 2014 Purchase Agreement through the issuance of 12,500,000 shares of its common stock at a weighted average price of $0.13 per share. On March 8, 2016, the Company voluntarily terminated the 2014 Purchase Agreement, effective March 9, 2016 (see Note 3).

In connection with the execution of the 2016 Purchase Agreement, the Company issued 105,000,000 shares of the Company’s common stock, at a price of $0.08 per share, for gross proceeds of $8,400.

On May 19, 2016, the Company’s shareholders approved the Charter Amendment increasing the number of authorized shares of common stock from 700 million shares to 1,100 million shares.

Warrants

In connection with the Series A Preferred Stock issuances in 2009, warrants to purchase 29,779,557 shares of the Company’s common stock, valued at $18,179, were outstanding through July 15, 2015. Due to extension of the expiration date of these warrants during 2010, they no longer contained anti-dilution provisions and were reflected as equity as they did not meet the criteria under FASB ASC 815 for liability treatment. Such warrants had exercise prices ranging between $0.48 and $0.49 and expired on July 15, 2015.

Non-Controlling

Interest

The Company’s Liquidmetal Golf subsidiary has the exclusive right and license to utilize the Company’s Liquidmetal alloy technology for purposes of golf equipment applications. The Company owns 79% of the outstanding common stock of Liquidmetal Golf. As of September 30, 2016, non-controlling interest was a deficit of $68. The December 31, 2015 non-controlling interest was a deficit of $62.

XML

Note 16 - Loss Per Common Share

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Earnings Per Share [Text Block]

1

6

.

Loss

Per Common Share

Basic earnings per share (“EPS”) is computed by dividing earnings (loss) attributable to common shareholders by the weighted average number of common shares outstanding for the periods. Diluted EPS reflects the potential dilution of securities that could share in the earnings.

Options to purchase 53,754,485 shares of common stock

, at prices ranging from $0.07 to $0.77 per share

, were outstanding at September 30, 2016, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 48,765,331 shares of common stock

, with prices ranging from $

0.07 to $0.17 per share

, outstanding at September 30, 2016 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Written call options to purchase 300,000,000 shares of common stock

, with prices ranging from $

0.15 to $0.25 per share

, outstanding at September 30, 2016 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss

.

Options to purchase 42,558,733 shares of common stock

, at prices ranging from $0.08 to $1.44 per share

, were outstanding at September 30, 2015, but were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss. Warrants to purchase 36,509,931 shares of common stock

, with prices ranging from $

0.17 to $0.19 per share

, outstanding at September 30, 2015 were not included in the computation of diluted EPS for the same period as the inclusion would have been antidilutive, given the Company’s net loss

.

XML

Note 17 - Commitments and Contingencies

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Commitments and Contingencies Disclosure [Text Block]

1

7

. Commitments and Contingencies

Operating Lease Commitments

The Company leases its offices and warehouse facilities under various lease agreements, certain of which are subject to escalations based upon increases in specified operating expenses or increases in the Consumer Price Index. As of September 30, 2016 and December 31, 2015, the Company had recorded $91 and $72, respectively, of deferred rent expenses.

Rent expense was $56 and $169 for the three and nine months ended September 30, 2016, respectively. Rent expense was $56 and $169 for the three and nine months ended September 30, 2015, respectively.

XML

Note 18 - Related Party Transactions

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]

1

8

. Related Party Transactions

The Company entered into a license agreement (the “IMG License Agreement”) with Innovative Materials Group, LLC (“IMG”), a California limited liability company which is majority owned by Mr. Kang, a former Chief Executive Officer and former Chairman of the Company

, to license certain patents and technical information for the limited purpose of manufacturing certain licensed products with the Company’s first generation die cast machines. The IMG License Agreement granted a non-exclusive license to certain product categories, as well as an exclusive license to specific types of consumer eyewear products and obligated IMG to pay the Company a running royalty based on its sales of licensed products through August 5, 2021. The Company recognized $

0 in royalty revenues from IMG during the three and nine months ended September 30, 2016 and 2015. The IMG License Agreement was terminated on March 8, 2016.

In March 2016, the Company executed an Amended and Restated Employment Agreement with Mr. Steipp. The Restated Employment Agreement provides for an employment term from its effective date through August 3, 2017, after which the employment term is renewed annually for successive one year terms, unless terminated by the Company or Mr. Steipp. Under the Restated Employment Agreement, Mr. Steipp is entitled to certain benefits if his employment is terminated involuntarily. These benefits include payment of a lump sum amount equal to one year of his annual base salary, continued insurance benefits at the Company’s expense for one year and accelerated vesting of equity awards. If the Company undergoes a “change of control”, and Mr. Steipp (i) is subsequently terminated without “cause”, or (ii) the Company subsequently takes certain actions that constitute “good reason”, and thereafter Mr. Steipp resigns, he will be entitled to a payment equal to one year of base salary, plus continued insurance benefits for two years, plus acceleration of vesting on equity awards and an extended time during which to exercise any equity awards that are stock options.

In March 2016, the Company entered into amended Change of Control Agreements with certain of its executive officers. The Change of Control Agreements provide that if the executive officer’s employment with the Company is terminated without cause during the one-year period after a change of control of the Company, then the terminated officer will receive lump sum severance compensation in an amount equal to twelve months of his then-current base salary. Under the agreements, each of the executive officers will also be entitled to the above-described severance compensation in the event he terminates his own employment within one year after a change of control because of a salary decrease, assignment to a lower-level position, or a required move of more than twenty-five miles. In addition, upon termination, all unvested stock options related to these officers will automatically and immediately vest and shall thereafter be exercisable in accordance with the terms and provisions of the applicable award agreements.

On March 10, 2016, the Company entered into the 2016 Purchase Agreement with Liquidmetal Technology Limited, providing for the purchase of up to 405,000,000 shares of the Company’s common stock for an aggregate purchase price of $63,400. Liquidmetal Technology Limited is a newly formed company owned by Professor Yeung Tak Lugee Li (“Professor Li”)

. In connection with the 2016 Purchase Agreement and also on March 10, 2016, the Company and Eontec, entered into a license agreement pursuant to which the Company and Eontec entered into a cross-license of their respective technologies. Eontec is a publicly held Hong Kong corporation of which Professor Li is the Chairman and majority shareholder. As of September 30, 2016, Professor Li is a greater-than-5% beneficial owner of the Company. Services procured from Eontec were $58 and $68 during the three and nine month periods ended September 30, 2016, respectively.

XML

Note 19 - Subsequent Event

9 Months Ended

Sep. 30, 2016

Notes to Financial Statements

Subsequent Events [Text Block]

1

9

.

Subsequent Event

2016 Purchase Agreement

On October 26, 2016, the Company issued and sold to the Investor an aggregate of 300,000,000 shares of Company’s common stock for an aggregate purchase price of $55,000, comprised of 200,000,000 shares at a price of $0.15 per share and 100,000,000 shares at a price of $0.25 per share. As a result of this closing, the Investor has completed its entire investment in the Company contemplated by the 2016 Purchase Agreement.

Stock Issuance Costs

On November 8, 2016, the Company reached a settlement with respect to any and all amounts due under an investment banking services agreement that resulted in the payment of success fees related to previously executed equity sales. This settlement, in the amount of $750, is deemed to terminate the investment banking services agreement, in all respects

, as of this settlement date. Such amounts have been reflected as an accrued liability as of September 30, 2016 and reflected as stock issuance costs as a reduction to additional paid in capital.

XML

Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

The Company’s revenue recognition policy complies with the requirements of ASC 605. Revenue is recognized when i) persuasive evidence of an arrangement exists, ii) delivery has occurred, iii) the sales price is fixed or determinable, iv) collection is probable and v) all obligations have been substantially performed pursuant to the terms of the arrangement. Revenues primarily consist of bulk amorphous alloy custom products and components, the tooling associated with production and prototyping projects, and licensing and royalty fees for the use of the Liquidmetal brand and certified Liquidmetal bulk amorphous alloys. Revenue is deferred and included in liabilities when the Company receives cash in advance for goods not yet delivered or if the licensing term has not begun.

License revenue arrangements in general provide for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include the grant of an exclusive or non-exclusive right to manufacture and/or sell products covered by patented technologies owned or controlled by the Company. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time.

Licensing revenues that are one time fees upon the granting of the license are recognized when i) the license term begins in a manner consistent with the nature of the transaction and the earnings process is complete, ii) when collectability is reasonably assured or upon receipt of an upfront fee, and iii) when all other revenue recognition criteria have been met. Pursuant to the terms of these agreements, the Company has no further obligation with respect to the grant of the license. Licensing revenues that are related to royalties are recognized as the royalties are earned over the related period.

Fair Value Measurement, Policy [Policy Text Block]

Fair Value

Measurements

The estimated fair values of financial instruments reported in the consolidated financial statements have been determined using available market information and valuation methodologies, as applicable. The fair value of cash, restricted cash, and short-term debt approximate their carrying value due to their short maturities.

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value based upon the following fair value hierarchy:

Level 1 — Quoted prices in active markets for identical assets or liabilities;

Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The Company has several financial instruments, namely warrant liabilities that are recorded at fair value on a periodic basis using Level 2 measurement inputs. These instruments are evaluated under the hierarchy of FASB ASC Subtopic 480-10, FASB ASC Paragraph 815-25-1 and FASB ASC Subparagraph 815-10-15-74 addressing the accounting for certain financial instruments with characteristics of both liabilities and equity and derivative accounting. The fair value of such instruments is estimated using the Black-Scholes option pricing model. Due to the presence of certain anti-dilution and exercise price reset provisions

, such instruments are required to be classified as liabilities (see Note 11).

As of September 30, 2016, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (current)		1,255		-		1,255		-
Warrant liabilities (long-term)		1,449		-		1,449		-

As of December 31, 2015, the following table represents the Company’s fair value hierarchy for items that are required to be measured at fair value on a recurring basis:

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (long-term)		59		-		59		-

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

Leases

In February 2016, the FASB issued an accounting standards update which modifies the accounting for leasing arrangements, particularly those arrangements classified as operating leases. This update will require entities to recognize the assets and liabilities arising from operating leases on the balance sheet. This guidance is effective for fiscal and interim periods beginning after December 15, 2018 and is required to be applied retrospectively to all leasing arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements.

Stock-Based Compensation

In March 2016, the FASB issued an accounting standards update which simplifies the accounting for share-based payment transactions, inclusive of income tax accounting and disclosure considerations. This guidance is effective for fiscal and interim periods beginning after December 15, 2016 and is required to be applied retrospectively to all impacted share-based payment arrangements. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Revenue from Contracts with Customers

In May 2014, the FASB issued an accounting standards update which modifies the requirements for identifying, allocating, and recognizing revenue related to the achievement of performance conditions under contracts with customers. This update also requires additional disclosure related to the nature, amount, timing, and uncertainty of revenue that is recognized under contracts with customers. This guidance is effective for fiscal and interim periods beginning after December 15, 2017 and is required to be applied retrospectively to all revenue arrangements. The Company is currently assessing the effects this guidance may have on its consolidated financial statements.

Ability to Continue as a Going Concern

In August 2014, the FASB issued an accounting standards update which requires an assessment of an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently addressed by U.S. auditing standards. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Inventory

In July 2015, the FASB issued an accounting standards update which modifies the requirements for measuring the value of inventory on a periodic basis. The new requirement will be to measure inventory at the lower of cost or net realizable value. This standard is effective for the fiscal years ending after December 15, 2016, and for annual periods and interim periods thereafter. The adoption of this guidance is not expected to have a significant impact on the Company’s consolidated financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company's present or future consolidated financial statements.

XML

Note 2 - Basis of Presentation and Recent Accounting Pronouncements (Tables)

9 Months Ended

Sep. 30, 2016

Notes Tables

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (current)		1,255		-		1,255		-
Warrant liabilities (long-term)		1,449		-		1,449		-

	Fair Value		Level 1		Level 2		Level 3
Warrant liabilities (long-term)		59		-		59		-

XML

Note 9 - Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2016

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

	September 30, 2016		December 31, 2015
Accrued payroll, vacation, and bonuses	$	783	$	766
Accrued stock issuance costs		750		-
Accrued audit fees		71		109
Straight-line rent accruals		91		72
Total		1,695		947

XML

Note 11 - Warrant Liabilities (Tables)

9 Months Ended

Sep. 30, 2016

Warrant [Member]

Notes Tables

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

	Visser MTA Agreement		July 2, 2012 Private Placement		2016 Purchase Agreement		Total
Beginning Balance - December 31, 2015	$	34	$	25	$	-		59
Original valuation- new issuances		-		-		760		760
Change in value of warrant liabilities, loss		657		539		689		1,885
Ending Balance - September 30, 2016	$	691	$	564	$	1,449	$	2,704
Included in current liabilities	$	691	$	564	$	-	$	1,255
Included in long-term liabilities	$	-	$	-	$	1,449	$	1,449

XML

Note 12 - Option Liabilities (Tables)

9 Months Ended

Sep. 30, 2016

Call Option [Member]

Notes Tables

Schedule of Derivative Liabilities at Fair Value [Table Text Block]

	200M Share			100M Share
	Call Option			Call Option			Total
Beginning Balance - December 31, 2015	$	-		$	-			-
Original valuation		489			22			511
Change in value of option liabilities, loss		2,442			171			2,613
Reclassification to shareholders' equity		(2,931	)		(193	)		(3,124	)
Ending Balance - September 30, 2016		-			-			-

XML

Note 2 - Basis of Presentation and Recent Accounting Pronouncements - Fair Value of Items Measured on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Fair Value, Measurements, Recurring [Member] | Warrant [Member] | Fair Value, Inputs, Level 1 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent
Fair Value, Measurements, Recurring [Member] | Warrant [Member] | Fair Value, Inputs, Level 2 [Member]
Derivative Liability, Current	1,255
Derivative Liability, Noncurrent	1,449	59
Fair Value, Measurements, Recurring [Member] | Warrant [Member] | Fair Value, Inputs, Level 3 [Member]
Derivative Liability, Current
Derivative Liability, Noncurrent
Fair Value, Measurements, Recurring [Member] | Warrant [Member]
Derivative Liability, Current	1,255
Derivative Liability, Noncurrent	1,449	59
Warrant [Member]
Derivative Liability, Current	1,255
Derivative Liability, Noncurrent	1,449
Derivative Liability, Noncurrent	$ 1,449	$ 59

XML

Note 3 - Significant Transactions (Details Textual) - USD ($)					1 Months Ended		3 Months Ended		9 Months Ended		21 Months Ended	25 Months Ended
	Oct. 26, 2016	Mar. 10, 2016	Dec. 06, 2013	Jan. 31, 2012	Feb. 28, 2015	Aug. 20, 2014	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2016	Aug. 25, 2016	May 19, 2016	May 18, 2016	Dec. 31, 2015	Oct. 24, 2013	Feb. 28, 2013	Feb. 27, 2013	Jul. 02, 2012	Jun. 02, 2012
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.15 [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues	200,000,000
Sale of Stock, Price Per Share	$ 0.15
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.15 [Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions							200,000,000		200,000,000		200,000,000	200,000,000
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues	100,000,000
Sale of Stock, Price Per Share	$ 0.25
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions							100,000,000		100,000,000		100,000,000	100,000,000
The 2016 Purchase Agreement [Member] | Shares of Common Stock Vested [Member] | Vest on March 10, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		2,609,913
The 2016 Purchase Agreement [Member] | Shares of Common Stock Vested [Member] | Vest on October 26, 2016 [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		7,456,896
The 2016 Purchase Agreement [Member] | Liquidmetal Technology Limited [Member]
Common Stock Purchase Agreement, Remaining Number of Shares Required to be Purchased before Forfeiture of RIghts														300,000,000
The 2016 Purchase Agreement [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues	300,000,000
Stock Issued During Period, Value, New Issues	$ 55,000,000
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors		405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors		$ 63,400,000
Stock Issued During Period, Shares, New Issues		105,000,000
Stock Issued During Period, Value, New Issues		$ 8,400,000
Sale of Stock, Price Per Share		$ 0.08
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions							$ 0.15		$ 0.15		$ 0.15	$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions							$ 0.25		$ 0.25		$ 0.25	$ 0.25
Common Stock Purchase Agreement, Value of Shares Authorized to Be Purchased No Later than 90 Days after Satisfaction of Certain Conditions							$ 55,000,000		$ 55,000,000		$ 55,000,000	$ 55,000,000		$ 55,000,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.07
The 2014 Purchase Agreement [Member] | Common Stock [Member]
Stock Issued During Period, Weighted Average Price Per Share										$ 0.13		$ 0.13
The 2014 Purchase Agreement [Member]
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors						$ 30,000,000
Stock Issued During Period, Shares, New Issues										12,500,000
Stock Issued During Period, Value, New Issues												$ 12,500,000
Common Stock, Par or Stated Value Per Share						$ 0.001
Common Stock Subscriptions, Term						3 years
Proceeds from Issuance of Common Stock										$ 1,568,000		$ 1,568,000
Private Placement [Member] | Visser MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							18,611,079		18,611,079		18,611,079	18,611,079				21,126,522					15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.17		$ 0.17		$ 0.17	$ 0.17				$ 0.16					$ 0.22
Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							17,572,000		17,572,000		17,572,000	17,572,000								18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.17		$ 0.17		$ 0.17	$ 0.17				$ 0.19				$ 0.384
Common Stock [Member]
Stock Issued During Period, Shares, New Issues									105,000,000
Stock Issued During Period, Value, New Issues									$ 105,000
Engel [Member]
Supply and License Agreement, Term				5 years
Exclusive License Agreement, Term			10 years
Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity					$ 2,000,000								$ 1,000,000
Line of Credit Facility, Interest Rate During Period					2.10%						2.10%
Interest Expense							$ 1,000	$ 1,000	$ 9,000	1,000
Liquidmetal Golf [Member]
Noncontrolling Interest, Ownership Percentage by Parent							79.00%		79.00%		79.00%	79.00%
Stock Issued During Period, Value, New Issues									$ 6,379,000
Common Stock, Shares Authorized							1,100,000,000		1,100,000,000		1,100,000,000	1,100,000,000		1,100,000,000	700,000,000	1,100,000,000	700,000,000	500,000,000	400,000,000
Common Stock, Par or Stated Value Per Share							$ 0.001		$ 0.001		$ 0.001	$ 0.001				$ 0.001
Proceeds from Issuance of Common Stock									$ 8,400,000	1,568,000
Interest Expense							$ 1,000	$ 1,000	$ 9,000	$ 1,000

XML

Note 4 - Liquidity and Capital Resources (Details Textual) - USD ($)		9 Months Ended
	Mar. 10, 2016	Sep. 30, 2016	Sep. 30, 2015	May 19, 2016	Dec. 31, 2015	Dec. 31, 2014
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.15 [Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions		200,000,000
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions		100,000,000
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors	405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors	$ 63,400,000
Common Stock Purchase Agreement, Number of Shares Obligated to Purchase	405,000,000
Stock Issued During Period, Shares, New Issues	105,000,000
Stock Issued During Period, Value, New Issues	$ 8,400,000
Sale of Stock, Price Per Share	$ 0.08
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions		$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions		$ 0.25
Common Stock Purchase Agreement, Value of Shares Authorized to Be Purchased No Later than 90 Days after Satisfaction of Certain Conditions		$ 55,000,000		$ 55,000,000
Net Cash Provided by (Used in) Operating Activities, Continuing Operations		(5,962,000)	$ (5,250,000)
Net Cash Provided by (Used in) Investing Activities, Continuing Operations		1,876,000	(2,656,000)
Net Cash Provided by (Used in) Financing Activities, Continuing Operations		7,715,000	2,281,000
Restricted Cash and Cash Equivalents, and Cash and Cash Equivalents, Carrying Value		6,407,000
Cash and Cash Equivalents, at Carrying Value		6,402,000	$ 4,384,000		$ 2,773,000	$ 10,009,000
Restricted Cash and Cash Equivalents, Current		5,000			$ 2,008,000
Stock Issued During Period, Value, New Issues		$ 6,379,000

XML

Note 5 - Inventory (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Inventory, Net	$ 227	$ 83

XML

Note 6 - Prepaid Expenses and Other Current Assets (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Prepaid Expense and Other Assets, Current	$ 452	$ 408

XML

Note 7 - Patents and Trademarks, Net (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Patents and Trademarks [Member] | Minimum [Member]
Finite-Lived Intangible Asset, Useful Life			10 years
Patents and Trademarks [Member] | Maximum [Member]
Finite-Lived Intangible Asset, Useful Life			17 years
Patents and Trademarks [Member]
Intangible Assets, Net (Excluding Goodwill)	$ 518		$ 518		$ 570
Amortization of Intangible Assets	25	$ 24	74	$ 74
Intangible Assets, Net (Excluding Goodwill)	$ 518		$ 518		$ 570

XML

Note 8 - Other Assets (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Other Assets	$ 36	$ 31

XML

Note 9 - Accrued Liabilities (Details Textual) - USD ($) $ in Thousands		9 Months Ended
	Nov. 08, 2016	Sep. 30, 2016	Dec. 31, 2015
Investor Identification Agreement [Member] | Subsequent Event [Member]
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$ 750
Investor Identification Agreement [Member]
Loss Contingency, Proceeds from Equity Transactions Payable, Percentage		5.00%
Loss Contingency, Proceeds from Equity Transactions Payable, Amount		$ 500
Accrued Liabilities, Current		$ 1,695	$ 947

XML

Note 9 - Accrued Liabilities - Schedule of Accrued Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Accrued payroll, vacation, and bonuses	$ 783	$ 766
Accrued stock issuance costs	750
Accrued audit fees	71	109
Straight-line rent accruals	91	72
Total	$ 1,695	$ 947

XML

Note 10 - Short-term Debt (Details Textual) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		21 Months Ended
	Feb. 28, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Dec. 31, 2015
Line of Credit [Member]
Short-term Debt		$ 0		$ 0		$ 0	$ 700,000
Line of Credit Facility, Interest Rate During Period	2.10%					2.10%
Interest Expense		1,000	$ 1,000	9,000	$ 1,000
Short-term Debt							$ 700,000
Interest Expense		$ 1,000	$ 1,000	$ 9,000	$ 1,000

XML

Note 11 - Warrant Liabilities (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Mar. 10, 2016	Dec. 31, 2015	Jul. 02, 2012	Jun. 30, 2012
Visser MTA Agreement [Member] | Warrant [Member]
Derivative Liability, Noncurrent
Derivative Liability	$ 691,000		$ 691,000			$ 34,000
Fair Value Assumptions, Expected Term			244 days
Fair Value Assumptions, Expected Volatility Rate			72.00%
Fair Value Assumptions, Risk Free Interest Rate			0.60%
Fair Value Assumptions, Expected Dividend Rate			0.00%
Fair Value Adjustment of Warrants			$ 657,000
Visser MTA Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	21,126,522		21,126,522			18,937,931		15,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.16		$ 0.16			$ 0.17		$ 0.22
Derivative Liability, Noncurrent								$ 4,260,000
Fair Value Adjustment of Warrants	$ (292,000)		$ 657,000
Warrant [Member] | Private Placement [Member]
Derivative Liability, Noncurrent							$ 5,053,000
Derivative Liability	564,000		$ 564,000			$ 25,000
Fair Value Assumptions, Expected Term			273 days
Fair Value Assumptions, Expected Volatility Rate			76.00%
Fair Value Assumptions, Risk Free Interest Rate			0.60%
Fair Value Assumptions, Expected Dividend Rate			0.00%
Fair Value Adjustment of Warrants			$ 539,000
Warrant [Member] | The 2016 Purchase Agreement [Member]
Derivative Liability, Noncurrent	1,449,000		1,449,000
Derivative Liability	1,449,000		$ 1,449,000
Fair Value Assumptions, Expected Term			9 years 160 days
Fair Value Assumptions, Expected Volatility Rate			120.00%
Fair Value Assumptions, Risk Free Interest Rate			1.60%
Fair Value Adjustment of Warrants			$ 689,000
Warrant [Member] | The 2016 Purchase Plan [Member]
Fair Value Assumptions, Expected Dividend Rate			0.00%
Warrant [Member]
Derivative Liability, Noncurrent	1,449,000		$ 1,449,000
Derivative Liability	$ 2,704,000		2,704,000			$ 59,000
Fair Value Adjustment of Warrants			$ 1,885,000
Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	17,572,000		17,572,000				18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.17		$ 0.17			$ 0.19	$ 0.384
Fair Value Adjustment of Warrants	$ (172,000)		$ 539,000
The 2016 Purchase Agreement [Member] | Warrants Valued as Liability [Member]
Derivative Liability, Noncurrent					$ 760,000
The 2016 Purchase Agreement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					10,066,809
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.07
Fair Value Adjustment of Warrants	(99,000)		689,000
Derivative Liability, Noncurrent	1,449,000		1,449,000			$ 59,000
Fair Value Adjustment of Warrants	$ (563,000)	$ (1,138,000)	$ 1,885,000	$ (1,326,000)
Class of Warrant or Right, Outstanding	48,765,331		48,765,331			36,509,931

XML

Note 11 - Warrant Liabilities - Summary of Changes in Warrant Liabilities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Jul. 02, 2012	Jun. 30, 2012
Visser MTA Agreement [Member] | Warrant [Member]
Derivative liabilities, balance			$ 34,000
Original valuation- new issuances
Change in value of warrant liabilities, loss			657,000
Derivative liabilities, balance	$ 691,000		691,000
Included in current liabilities	691,000		691,000
Included in long-term liabilities
Visser MTA Agreement [Member]
Change in value of warrant liabilities, loss	(292,000)		657,000
Included in long-term liabilities							$ 4,260,000
Warrant [Member] | Private Placement [Member]
Derivative liabilities, balance			25,000
Original valuation- new issuances
Change in value of warrant liabilities, loss			539,000
Derivative liabilities, balance	564,000		564,000
Included in current liabilities	564,000		564,000
Included in long-term liabilities						$ 5,053,000
Warrant [Member] | The 2016 Purchase Agreement [Member]
Derivative liabilities, balance
Original valuation- new issuances			760,000
Change in value of warrant liabilities, loss			689,000
Derivative liabilities, balance	1,449,000		1,449,000
Included in current liabilities
Included in long-term liabilities	1,449,000		1,449,000
Warrant [Member]
Derivative liabilities, balance			59,000
Original valuation- new issuances			760,000
Change in value of warrant liabilities, loss			1,885,000
Derivative liabilities, balance	2,704,000		2,704,000
Included in current liabilities	1,255,000		1,255,000
Included in long-term liabilities	1,449,000		1,449,000
Private Placement [Member]
Change in value of warrant liabilities, loss	(172,000)		539,000
The 2016 Purchase Agreement [Member]
Change in value of warrant liabilities, loss	(99,000)		689,000
Change in value of warrant liabilities, loss	(563,000)	$ (1,138,000)	1,885,000	$ (1,326,000)
Included in long-term liabilities	$ 1,449,000		$ 1,449,000		$ 59,000

XML

Note 12 - Option Liabilities (Details Textual) - USD ($)			3 Months Ended		9 Months Ended
	Aug. 11, 2016	May 19, 2016	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.15 [Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions			200,000,000		200,000,000
The 2016 Purchase Agreement [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member]
Common Stock Purchase Agreement, Remaining Number of Shares to be Purchased, After the Satisfaction of Certain Conditions			100,000,000		100,000,000
The 2016 Purchase Agreement [Member] | The 200 Million Share, Call Option [Member]
Original Valuation, Options					$ 489,000
Derivative Liability, Current		$ 2,931,000
Fair Value Adjustment of Options					2,442,000
The 2016 Purchase Agreement [Member] | The 100 Million Share, Call Option [Member]
Original Valuation, Options					22,000
Derivative Liability, Current		$ 193,000
Fair Value Adjustment of Options					$ 171,000
The 2016 Purchase Agreement [Member] | Call Option [Member]
Fair Value Assumptions, Expected Term		91 days
Fair Value Assumptions, Expected Volatility Rate		85.00%
Fair Value Assumptions, Risk Free Interest Rate		0.31%
Fair Value Assumptions, Expected Dividend Rate		0.00%
The 2016 Purchase Agreement [Member] | Liquidmetal Technology Limited [Member]
Common Stock Purchase Agreement, Remaining Number of Shares Required to be Purchased before Forfeiture of RIghts		300,000,000
Gain (Loss) on Contract Modification	$ (2,126,000)
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Purchase Price per Share, After Satisfaction of Certain Conditions			$ 0.15		$ 0.15
Common Stock Purchase Agreement, the Other Purchase Price per Share, No Later than 90 Days after Satisfaction of Certain Conditions			$ 0.25		$ 0.25
The 200 Million Share, Call Option [Member]
Original Valuation, Options					$ 489,000
Derivative Liability, Current			$ 0		0		$ 0
Fair Value Adjustment of Options					2,442,000
The 100 Million Share, Call Option [Member]
Original Valuation, Options					22,000
Derivative Liability, Current			0		0		$ 0
Fair Value Adjustment of Options					171,000
Original Valuation, Options					511,000
Fair Value Adjustment of Options					2,613,000
Gain (Loss) on Contract Modification			$ (2,126,000)		$ (2,126,000)

XML

Note 12 - Option Liabilities - Summary of the Changes in Option Liabilities (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
The 200 Million Share, Call Option [Member]
Balance			$ 0
Original valuation			489,000
Loss from change in value of option liabilities			2,442,000
Reclassification to shareholders' equity			(2,931,000)
Balance	$ 0		0
The 100 Million Share, Call Option [Member]
Balance			0
Original valuation			22,000
Loss from change in value of option liabilities			171,000
Reclassification to shareholders' equity			(193,000)
Balance	0		0
Call Option [Member]
Balance			0
Balance	0		0
Original valuation			511,000
Loss from change in value of option liabilities			2,613,000
Reclassification to shareholders' equity			$ (3,124,000)

XML

Note 13 - Other Long-term Liabilities (Details Textual) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Other Liabilities, Noncurrent	$ 856	$ 856
Period for Outstanding Liability	5 years

XML

Note 14 - Stock Compensation Plans (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015	Jan. 27, 2015	Apr. 04, 2002
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant							10,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	507,500		507,500		822,000
Equity Incentive Plan 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	25,746,985		25,746,985		25,988,734
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			2,000,000
Equity Incentive Plan 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						40,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	27,500,000		27,500,000		15,100,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			14,400,000
Allocated Share-based Compensation Expense	$ 365	$ 320	$ 1,083	$ 1,035

XML

Note 15 - Shareholders' Equity (Details Textual) - USD ($)				1 Months Ended	9 Months Ended		12 Months Ended		25 Months Ended
	Mar. 10, 2016	Nov. 08, 2013	Jul. 17, 2013	Jun. 30, 2012	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2014	Dec. 31, 2013	Sep. 30, 2016	May 19, 2016	May 18, 2016	Dec. 31, 2015	Jul. 15, 2015	Sep. 09, 2014	Oct. 24, 2013	Feb. 28, 2013	Feb. 27, 2013	Jul. 02, 2012
Private Placement [Member] | Visser MTA Agreement [Member]
Stock Issued During Period, Shares, New Issues				30,000,000
Private Placement [Member] | Senior Convertible Notes [Member] | Weighted Average [Member]
Debt Instrument, Convertible, Conversion Price			$ 0.0774
Private Placement [Member] | Senior Convertible Notes [Member]
Debt Conversion, Converted Instrument, Shares Issued			163,641,547
Debt Instrument, Periodic Payment, Principal			$ 12,000,000
Debt Instrument, Periodic Payment, Interest			$ 680,000
Private Placement [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					17,572,000				17,572,000									18,750,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.17				$ 0.17			$ 0.19						$ 0.384
Common Stock Purchase Agreement [Member] | Weighted Average [Member]
Share Price							$ 0.19
Common Stock Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues							85,355,615
Stock Issued During Period, Shares, Other		2,666,667
Stock Issued During Period, Value, New Issues							$ 16,000,000
The 2014 Purchase Agreement [Member] | Common Stock [Member]
Stock Issued During Period, Weighted Average Price Per Share						$ 0.13			$ 0.13
The 2014 Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues						12,500,000
Stock Issued During Period, Value, New Issues									$ 12,500,000
Common Stock, Shares Covered by Registration Statement														75,000,000
Proceeds from Issuance of Common Stock						$ 1,568,000			$ 1,568,000
The 2016 Purchase Plan [Member]
Stock Issued During Period, Shares, New Issues	105,000,000
Stock Issued During Period, Value, New Issues	$ 8,400,000
Sale of Stock, Price Per Share	$ 0.08
Liquidmetal Golf [Member]
Noncontrolling Interest, Ownership Percentage by Parent					79.00%				79.00%
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights													$ 0.48
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights													$ 0.49
Series A Preferred Stock [Member]
Conversion of Stock, Shares Converted								506,936
Class of Warrant or Right, Number of Securities Called by Warrants or Rights													29,779,557
Common Stock [Member]
Stock Issued During Period, Shares, New Issues					105,000,000
Conversion of Stock, Shares Issued								16,896,070
Stock Issued During Period, Value, New Issues					$ 105,000
Preferred Stock, Shares Outstanding					0			0	0			0
Common Stock, Shares Authorized					1,100,000,000				1,100,000,000	1,100,000,000	700,000,000	1,100,000,000			700,000,000	500,000,000	400,000,000
Stock Issued During Period, Value, New Issues					$ 6,379,000
Proceeds from Issuance of Common Stock					8,400,000	$ 1,568,000
Warrants and Rights Outstanding					18,179,000				$ 18,179,000			$ 18,179,000	$ 18,179,000
Stockholders' Equity Attributable to Noncontrolling Interest					$ (68,000)				$ (68,000)			$ (62,000)

XML

Note 16 - Loss Per Common Share (Details Textual) - $ / shares	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Jul. 15, 2015
Employee Stock Option [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.07	$ 0.08
Employee Stock Option [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.77	$ 1.44
Employee Stock Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	53,754,485	42,558,733
Warrant [Member] | Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.07	$ 0.17
Warrant [Member] | Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.17	$ 0.19
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	48,765,331	36,509,931
Written Call Options [Member] | Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.15
Written Call Options [Member] | Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.25
Written Call Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	300,000,000
Minimum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.48
Maximum [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.49

XML

Note 17 - Commitments and Contingencies (Details Textual) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Deferred Costs, Leasing, Net, Current	$ 91		$ 91		$ 72
Operating Leases, Rent Expense, Net	$ 56	$ 56	$ 169	$ 169

XML

Note 18 - Related Party Transactions (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Mar. 10, 2016
Innovative Materials Group [Member]
Royalty Revenue	$ 0	$ 0	$ 0	$ 0
Chairman of Eontec [Member] | Minimum [Member]
Beneficial Ownership Percentage	5.00%		5.00%
Eontec [Member] | License Agreement [Member]
Related Party Transaction, Amounts of Transaction	$ 58,000		$ 68,000
The 2016 Purchase Agreement [Member]
Common Stock Purchase Agreement, Number of Shares Authorized to Issue and Sell to Investors					405,000,000
Common Stock Purchase Agreement, Value of Shares Authorized to Issue and Sell to Investors					$ 63,400,000

XML

Note 19 - Subsequent Event (Details Textual) - USD ($)				9 Months Ended
	Nov. 08, 2016	Oct. 26, 2016	Mar. 10, 2016	Sep. 30, 2016
The 2016 Purchase Agreement [Member] | Subsequent Event [Member] | Common Stock, Purchase Price per Share of $0.15 [Member]
Stock Issued During Period, Shares, New Issues		200,000,000
Sale of Stock, Price Per Share		$ 0.15
The 2016 Purchase Agreement [Member] | Subsequent Event [Member] | Common Stock, Purchase Price per Share of $0.25 [ Member]
Stock Issued During Period, Shares, New Issues		100,000,000
Sale of Stock, Price Per Share		$ 0.25
The 2016 Purchase Agreement [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues		300,000,000
Stock Issued During Period, Value, New Issues		$ 55,000,000
The 2016 Purchase Agreement [Member]
Stock Issued During Period, Shares, New Issues			105,000,000
Stock Issued During Period, Value, New Issues			$ 8,400,000
Sale of Stock, Price Per Share			$ 0.08
Subsequent Event [Member] | Investor Identification Agreement [Member]
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$ 750,000
Stock Issued During Period, Value, New Issues				$ 6,379,000